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Foreword 
Every citizen has an uncompromised ri ght to a healthy living environment 1 . 
Unfortunately, as we can alm ost daily r ead from the newspapers, this is not yet 
reality in Finland or elsew here in the E urope. Air pollution is estim ated to be the 
leading cause of environm ental burden of disease in Europe 2. While more than half 
of this burden originates from  outdoor air pollution, quite regularly m any people 
including school children, adults and seni or citizens are found living, studying and 
working in buildings seriously affected by m oisture, dampness and mould and other 
problems generated by indoor sources of pollution. 
In the context of a European Union research project HEALTHVENT 3, 4, aiming at 
defining health-based E uropean guidelines for ventilation, w e developed a 
quantitative model for evaluating the im pacts of ventilation on the population 
exposures to pollution from indoor and outdoor sources. The current report presents 
an overview of the intrinsic gentle balance of ventilation and indoor and outdoor 
sources of pollution and estim ates of the health effects, aim ing at a quantitative 
understanding of the underlying m ass-balance processes, and ultim ately, 
development of inform ed control policie s, that would allow us to reach the 
uncompromised safe state of our living environment. 
 
 
Otto Hänninen 
 
May 2013 
Kuopio, Finland 
 
                                                        
 
 
1 World Health Organization, 2000. The Right to Healthy Indoor Air. Meeting Report 15-17. May, 
2000. http://www.euro.who.int/document/e69828.pdf 
2 Hänninen O, Knol A (eds.), 2011. European pers pectives on Environmental Burden of Disease; 
Estimates for nine stressors in six countri es. THL Reports 1/2011, Helsinki, Finland. . 
http://www.thl.fi/thl-client/pdfs/b75f6999-e7c4-4550-a939-3bccb19e41c1 
3 Project website http://www.healthvent.byg.dtu.dk  
4 http://www.efanet.org/healthvent-results-presented-at-the-european-parliament/  
fficient r cti   
i  
 
 
THL — Report 2/2013 5 Burden of Disease from Residential Indoor Air Exposures 
 
 
Contributors 
 
This report presents an overview of results from  a num ber of national and 
international studies. T he report is a ke y contribution to the national TEKAISU 
project and the work has especially benefited from  the work conducted in the 
HEALTHVENT project, but includes substa ntial inputs also from the following 
projects and persons that have had key contributions to the evaluations presented: 
 
TEKAISU (Ministry of Social Affairs and Health) 
Arja Asikainen, National Institute for Health and Welfare, Kuopio, Finland 
Otto Hänninen, National Institute for Health and Welfare, Kuopio, Finland 
Martin Taubel, National Institute for Health and Welfare, Kuopio, Finland 
Jouni Tuomisto, National Institute for Health and Welfare, Kuopio, Finland 
 
HEALTHVENT (???DG Sanco) 
Wolfgang Bischof, University Clinic Dresden, Germany 
Thomas Hartmann, University Clinic Dresden, Germany 
Paolo Carrer, University of Milan, Italy 
Eduardo de Oliveira Fernandes, University of Porto, Portugal 
Olli Seppänen, REHVA, Brussels, Belgium 
Stelios Kephalopoulos, EC Joint Research Centre, Ispra, Italy 
Pawel Wargocki, Techical University of Denmark 
 
PM SIZEx (Academy of Finland) 
Pasi Lipponen, National Institute for Health and Welfare, Kuopio, Finland 
 
TRANSPHORM (EU FP-7) 
Riikka Sorjamaa, National Institute for Health and Welfare, Kuopio, Finland 
 
ULTRA (EU FP-4) 
Timo Lanki, National Institute for Health and Welfare, Kuopio, Finland 
Juha Pekkanen, National Institute for Health and Welfare, Kuopio, Finland 
 
EXPOLIS (EU FP-4) 
Matti Jantunen, National Institute for Health and Welfare, Kuopio, Finland 
Efficient reduction   
of indoor ex s r s  
 
 
THL — Report 2/2013 6 Burden of Disease from Residential Indoor Air Exposures 
 
 
Additionally, we would like to express our warmest thanks to the numerous national 
and international scientists that have directly and indirectly contributed by providing 
expertize to the current w ork at scientif ic conferences, project m eetings, e-mail 
correspondence and face to face discussions. While it is impossible to list everybody 
deserving to be m entioned, we would like to express our special gratitude to Sani 
Dimitroloupoulou, author of the scientific review of ventilation studies. 
 
 
This work has been financially supporte d by the EU Health Programme projects 
HEALTHVENT, Grant Nr. 2009 12 08 and IAIAQ, Grant Nr. 2009 62 02, Academy 
of Finland Contract 133792 (PM  Sizex), EU Contracts FP7-ENV-2009-1-243406 
(TRANSPHORM), ENV4-CT95-0205 (ULTRA), EU Sixth Framework Programme 
- Priority 6.3 Global Change and Ecos ystems Grant nr. GOCE -CT-2006-036913-2 
(HEIMTSA), EU FP6 proj ect EnVIE, SSPE-CT-2004- 502671, and M inistry of 
Social Affairs and Health and intram ural funding for projects EBoDE and 
TEKAISU. 
 
Efficient reduction   
of indoor ex s r s  
 
 
THL — Report 2/2013 7 Burden of Disease from Residential Indoor Air Exposures 
 
 
Symbols and abbreviations 
 
ACH Air changes per hour, a measure of AER (see below) 
AER, a Air exchange rate, expressed as air changes per hour (ach, h-1) 
CV Coefficient of variation (CV=SD/mean) 
CO, CO2 Carbon monoxide, carbon dioxide 
GSD Geometric standard deviation 
IAQ Indoor air quality 
lps ventilation rate in litres per second 
lps pp ventilation rate litres per second per person 
n50 air leakage rate per hour at 50 Pa pressure test conditions 
PM2.5, PM10 Particulate matter (aerodynamic size <2.5 and 10 µm, respectively) 
pp per person 
SD Standard deviation 
THL National Institute for Health and Welfare 
VOC Volatile organic compounds 
WHO World Health Organization 
WP Work Package 
 
 
The following variables are used in the HEALTHVENT health impact model. 
 
Concentration variables (µg/m3, Bq/m3) 
Ca Outdoor (ambient) concentration  
Ci Indoor concentration 
Cai Indoor concentration of outdoor pollution 
Cig Indoor concentration of indoor generated pollution 
Finf Infiltration factor (fraction) 
a, aer Air exchange rate (ach or h-1) 
P Penetration efficiency (fraction) of outdoor pollutant entering indoors 
k Decay rate (h-1) of a pollutant indoors 
f Adjustment factor (unitless) of air exchange rate 
G Indoor source strength (µg/h) 
Q Ventilation volume (m3/h) 
V Volume of indoor space (m3) 
 
Burden of disease variables 
 
BoD Burden of disease (DALY, in years) 
DALY Disability-adjusted life years 
DW Disability weight (0=perfect health, 1=death) 
L Average length of a disease (in years) 
PAF Population attributable fraction (of a disease) 
RR Relative risk 
YLD Years lived with disability (DALY) 
YLL Years of life lost (due to premature mortality) (DALY) 
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Tiivistelmä 
Otto Hänninen and Arja Asikainen (Eds.). Efficient reduction of indoor exposures - 
Health benefits from  optimizing ventilation, filtration and indoor source controls. 
[Optimoidun ilmanvaihdon terveyshyödyt - Sisäilma-altistuksen tehokas alentam inen]. 
Terveyden ja hyvinvoinnin laitos (THL).  93 sivua. Helsinki 2013. ISBN 9 78-952-
245-821-6 (painettu); ISBN 978-952-245-822-3 (verkkojulkaisu) 
 
Epäpuhtaan sisäilman aiheuttamaksi tautikuormaksi on arvioitu vuosittain EU:ssa yli 
2 miljoonaa menetettyä tervettä elinvuotta  (disability-adjusted life years, D ALY), 
joista Suomessa 13 300. Täm ä tautikuorma aiheutuu osittain sisäilm an 
epäpuhtauksista, mutta pääasiallinen teki jä ovat ulkoilm an epäpuhtaudet, jotka 
pääsevät sisätiloihin ilm anvaihdon ja ilm avuotojen kautta. K oska epäpuhtauksien 
lähteinä toimii sekä sisä- että ulkoilm a, on il manvaihdon oikeaksi säätäm inen 
haasteellista. Tämä raportti tarjoaa v iitekehyksen vaikuttavien tekijöiden 
tasapainottamiseksi. 
Maailman terveysjärjestö (W HO) julkaisi ilmanlaadun ohjearvot kosteus- ja 
homevaurioiden aiheuttamille epäpuhtauksille vuonna 2009. Tästä huolim atta 
näiden vaurioiden aiheuttam ista ongelmista raportoidaan sanom alehdissä lähes 
päivittäin, vahvistaen ettei ongelm aa ole onni stuttu ratkaisemaan Suomessa eikä 
muissakaan maissa. WHO:n ulkoilman ohjearvot ilmestyivät jo vuonna 2000, m utta 
arviolta 90 % eurooppalaisista asuu edell een aluilla joissa ohjearvo pienhiukkasille 
(10 µg/m3) ylitetään. Suomessa tilanne on parem pi, ja WHO:n PM2.5 vuosiohjearvo 
ylittyy vain suppeilla alueilla. Tästä huolim atta yli 60 %  sisäympäristön 
aiheuttamasta tautikuormasta johtuu sisäilmaan kulkeutuneista ulkoilman saasteista 
myös Suomessa. 
Eurooppalaiset terveysperustaiset ilm anvaihdon ohjeet koottiin EU - 
rahoitteisessa HEALTHVENT-projektissa (2010-2013). Tässä raportissa esitetään 
numeerinen menetelmä sisä- ja ulkoilm an altisteiden tautikuorm a-arvioiden 
tasapainottamiseksi merkittävimmille altisteille, ja tuotetaan tarvittavat tiedot 
tautikuorman vähentämiseen tähtäävien tehokkaiden rajoittam ispolitiikkojen 
muodostamiselle. Arviot huomioivat kaikki m erkittävät tiedossa olevat 
epäpuhtaudet, vaikkakin uutta tietoa vähe mmän merkittävistä riskitekijöistä tulee 
jatkuvasti esille. Nämä riskitekijät voivat olla merkittäviä pienille erityisryhmille. 
Tämän raportin tulokset varm istavat, että sisäilman terveysriskejä ei voida 
alentaa hyväksyttävälle tasolle ottam atta huomioon kaikkia altistukseen vaikuttavia 
tekijöitä: ulkoilman lähteet, ulkoilman epäpuhtauksien infiltraatio, sisäilmalähteet ja 
ilmanvaihto. Kaikkien näiden tekijöiden  tehokas hallinta on ainoa keino varm istaa 
terveellinen sisäilma kaikissa tilanteissa.  
 
Avainsanat: Sisäilman laatu; ilmanvaihto; sisäympäristön altistus; tautikuorma 
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Sammandrag 
Otto Hänninen and Arja Asikainen (Eds.). Efficient reduction of indoor exposures - 
Health benefits from  optimizing ventilation, filtration and indoor source controls. 
[Effektiv minskning av inom husexponeringar - Hälsofördelar m ed optimerad 
ventilation, luftfiltrering och kontroll av  inomhuskällor]. Terveyden ja hyvinvoinnin 
laitos (THL) (Institutet för hälsa och välf ärd).  93 sidor. H elsingfors 2013. ISBN  
978-952-245-821-6 (tryckt); ISBN 978-952-245-822-3 (nätpublikation) 
 
Den årliga sjukdom sbördan orsakad av dålig inom husluftkvalitet uppskattas 
motsvara en förlust av över två miljoner friska levnadsår i EU och 13 300 i Finland. 
Denna börda orsakas av föroreningskällo r som finns i inom husluften, men framför 
allt också av förorenad utom husluft som används för ventilation. E ftersom 
föroreningskällor finns i både inom hus- och utom husluften, är det utm anande att 
välja den bästa ventilationsstrategin. D enna rapport ger en kvantitativ ram  för att 
hitta en balans mellan de påverkande faktorerna. 
Världshälsoorganisationen publicerade år 2009 riktlinjer för inomhusluftkvalitet, 
för föroreningar orsakade av fukt och m ögel. Trots det bekräftar nästan dagliga 
rapporter i tidningar att problem et inte har lösts i Finland eller någon annanstans. 
Luftföroreningar utomhus spelar en stor roll i uppkomsten av föroreningar inomhus. 
Cirka 90 % av européerna bor i om råden där Världshälsoorganisationens riktvärden 
för PM2,5 (10 µg/m
3) inte uppnås. I Finland är situationen bättre m ed bara små delar 
av landet som  överskrider W HO:s årsriktvärde för PM 2,5. Ändå utgör 
föroreningarna från utom husluften fortfarande också i Finland över 60 %  av 
sjukdomsbördan som är orsakad av inomhusmiljön. 
De hälsobaserade europeiska riktlinje rna för ventilation har utvecklats under 
2010–2013 i det EU-finansierade projekte t HEALTHVENT. Syftet m ed denna 
rapport är att utveckla en num erisk beräkningsmetod för sjukdomsbördan som 
orsakas av inom hus- och utom huskällor och presentera nödvändig 
bakgrundsinformation för utvecklingen av en  effektiv kontrollpolitik för att m inska 
bördan. Alla de större kända föroreni ngskällorna behandlas i rapporten, men nya 
bevis på m indre riskfaktorer kom mer kontinuerligt fram. Särskilt för vissa m indre 
befolkningsgrupper kan sådana nya risker spela en betydande roll. 
De resultat som presenteras i denna rapport visar övertygande att de hälsorisker 
som orsakas av exponeringar via inomhusluften inte kan reduceras till en acceptabel 
nivå utan att redovisa alla viktiga faktorer som påverkar exponeringar: 
utomhuskällor och infiltration, inom huskällor och ventilation. A tt ha full kontroll 
över alla dessa faktorer är det enda m öjliga sättet att ge hälsosam  inomhusluft till 
alla. 
 
Nyckelord: Inomhusluftkvalitet, ventilation, luftväxling, inom husexponering, 
sjukdomsbörda 
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Abstract 
Otto Hänninen and Arja Asikainen (Eds.). Efficient reduction of indoor exposures - 
Health benefits from  optimizing ventilation, filtration and indoor source controls. 
Terveyden ja hyvinvoinnin laitos (THL).  93 pages. Helsinki 2013. ISBN 978-952-
245-821-6 (printed) ISBN 978-952-245-822-3 (online publication) 
 
The annual burden of disease caused by inadequate indoor air quality is estim ated to 
correspond a loss of over 2 m illion healthy life years in the EU  and 13 300 in 
Finland. This burden is caused by indoor sources of pollution, but especially also by 
polluted outdoor air used to ventilate i ndoor spaces. Because sources of pollution 
reside in both indoor and outdoor air, selecting the best ventilation strategy is tricky. 
The current report provides a quantitative framework for balancing betw een the 
influential factors. 
World Health Organization published indoor air quality guidelines for dam pness 
and mould in 2009. Nevertheless alm ost daily reports in newspapers painfully 
confirm that the problem has not been solv ed in Finland or el sewhere. Outdoor air 
pollution plays a significant role in creating the indoor exposures. Approximately 90 
% of Europeans live in areas where the W orld Health Organization Guideline for 
PM2.5 (10 µg/m
3) is not attained. In Finland the situation is better w ith only limited 
areas exceeding the annual WHO PM2.5 Guideline. Nevertheless, still also in Finland 
over 60% of the burden of disease cause d by indoor exposures is estim ated to 
originate from outdoor air. 
European health-based ventilation guidelines w ere developed in 2010-2013 in 
the EU-funded HEALTHVENT project. The aim of the current work is to develop a 
mass-balance framework for balancing the impacts of the major sources of burden of 
disease, providing background inform ation for the development of efficient control 
policies to reduce the burden. All known major pollutants are covered; however, 
new evidence on smaller risk factors becomes continuously available. Especially for 
certain smaller population groups such emerging risks can play a significant role.  
The results presented in this report s how convincingly that the health risks 
caused by indoor exposures cannot be re duced to an acceptable level without 
accounting for all m ajor factors m odifying exposures: outdoor sources and 
infiltration, indoor sources, and ventilati on. Acting efficiently on all is the only 
possible way forward in providing healthy indoor air to all. 
 
Keywords: Indoor air quality; ventilation; air exchange; indoor exposures; burden of 
disease 
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To the Reader 
Health is a crucial prerequisite for a functional society, proper performance at school 
and work, and a significant determ inant of life satisfaction and wellbeing. W orld 
Health Organization has defined criteria for health and has set healthy indoor 
environments as every a basic right (WHO, 2000a). 
Recently conducted EBoDE (Hänninen & Knol, 2011; Hänninen et al., 2013) and 
SETURI (Pekkanen, 2010; Hänninen et al., 2010) studies, supported by the Ministry 
of Health and Social Affairs, have conf irmed that environm ent is continuously a 
significant contributor to the burden of dise ase in Europe. Even in Finland, which 
represents the cleaner part of our contin ent regarding m ost exposures, the health 
risks remain unacceptably high and especia lly air pollutants represent substantial 
risks. 
The importance of indoor air has been  long recognized. Already in the 1980’s 
Aino Nevalainen (1989) studied m icrobial indoor exposures, but only relatively 
recently the quantitative assessm ents of th e health risks caused by air pollution 
exposures have been able to com pare the relative roles of indoor and outdoor 
sources on the health risks. The EnVIE study (de Oliveira Fernandes et al., 2009) 
was the first attem pt to use European wide data com bined with burden of disease 
methodology to provide com parable risk es timates for a range of m ajor indoor air 
pollutants. The work was taken forward in the IAIAQ-project (Jantunen et al., 2010) 
in terms of significantly im proving the data coverage and exposure assessm ents. 
These studies form the ground on which the current report is built. 
Efficient policies to reduce environm ental health risks can only be developed, if 
the risks are first w ell known in both qualitative as w ell as quantitative term s. The 
Ministry of Health and Social Affair s is currently actively pressing forward 
development of policies to im prove environmental health. One of the leading 
activities in this field is the TEK AISU-project (2011-2015), aim ing at scientific 
prioritization of policy options in term s of their projected efficiencies. The work 
includes identification of alternative expos ure control policies, evaluation of their 
efficiencies and prioritization of them  according to their risk reduction potentials. 
The current report represents an essential part of the TEKAISU process by providing 
mass-balance estimates of the roles of indoor and outdoor sources and ventilation on 
the health risks of indoor air. 
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1  Introduction 
Indoor air quality (IAQ) in buildings is prescribed by existing minimum standards 
for ventilation and the result is far too often poor. At present ventilation standards 
(e.g. EN15251) define ventilation in non-industrial buildings to meet comfort 
requirements of occupants, specified by the percentage of dissatisfied with indoor air 
quality and/or by the intensity of odour. While comfort is an important factor, it does 
not fully cover more serious health impacts like asthma, allergies, chronic 
obstructive pulmonary disease, cardiovascular diseases, lung cancer and acute 
toxication that are caused by exposures to pollutants present in indoor air. There are 
no European guidelines which recommend how the buildings should be ventilated 
for the best health of the occupants. 
Large range of pollutants has been associated with health effects. In detailed 
carefully designed studies even small impacts can be observed with high statistical 
accuracy. All identified hazards, however, do not represent equal public health 
concerns, and legislation and standards naturally should focus on factors that have 
wide importance.  
 
 
Figure 1. Countries included in international IAQ assessments presented in this 
report and referred to as EU26 (EU27 excluding Malta). 
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A quantitative risk assessment model for indoor exposures has been developed in a 
series of studies participated and coordinated by National Institute for Health and 
Welfare. The original EnVIE study presented a conceptual framework for linking 
sources to exposures and health impacts, and evaluate these from the perspective of 
policies (de Oliveira Fernandes et al, 2009). The EnVIE model was further 
elaborated in the IAIAQ-project, in which the coverage of the exposure data was 
substantially improved Due to the lack of exposure data Malta is missing from the 
assessments covering thus 99.92% of the EU27 population (Figure 1). 
The exposures that were identified as playing a significant role as public health 
risks range from particulate matter (PM, e.g. PM2.5 and PM10) to volatile organic 
compounds (VOCs) (Table 1). Much larger number of pollutants have been 
associated with health responses, but either play a small role from the point of view 
of public health, or pose challenges for the exposure assessment or quantification of 
the burden of disease. Thus the discussion in this report is based on the assumption 
that the exposures listed in Table 1 represent the most important indoor air quality 
determining factors and should be accounted for in balancing source controls and 
ventilation for optimal health. Health determinants of housing in general are 
discussed in WHO 2011, safe levels of specific chemicals indoors in WHO 2010 and 
dampness and mould specifically in WHO 2009. 
 
Table 1. Major sources of exposures occurring in indoor air and significantly 
contributing to the public health risks. 
 
 
	  
Major exposures  Examples of sources 
	   	  	   	  	  
Indoor origin  
Particulate	  matter	  (PM2.5)	   Cooking,	  cleaning,	  living,	  smoking…	  
Dampness	  and	  moulds	   Structural	  moisture,	  humidity,	  biological	  growth	  
Second	  hand	  smoke	  (SHS)	   Smoking	  
Radon	  (Rn)	   Soil,	  (construction	  materials)	  
Carbon	  monoxide	  (CO)	   Combustion	  devices	  
Volatile	  organic	  compounds	  (VOC)	   Building	  materials,	  furniture,	  consumer	  products	  
-­‐	  formaldehyde,	  benzene,	  etc.	   	  	  
	  	   	  	  
Outdoor origin 
Particulate	  matter	  (PM2.5)	   Traffic,	  combustion	  etc.	  
Bioaerosols	  (pollens)	   Vegetation	  
Ozone	  (O3)	   Atmospheric	  photochemistry	  
Volatile	  organic	  compounds	  (VOC)	   Combustion	  processes	  etc.	  
-­‐	  benzene	  etc.	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1.1 Ventilation and health 
 
Ventilation is one of the technologies used to control the quality of indoor 
environment, including thermal conditions and humidity, structural m oisture and 
mould growth, extraction and dilution of  emissions from indoor sources and 
infiltration of am bient air pollution indoors. These roles of ventilation are 
highlighted in the flow chart in Figure 2, developed as part of the health-based 
ventilation guidelines in the HEALTHVENT-project. 
Emission sources are the prim ary causes of exposures to indoor and outdoor 
originating pollutants. W hen discussing optimal ventilation, it should be 
remembered that source control is alm ost always m ore efficient in controlling 
exposures than diluting the emissions into the occupied space. The current document 
aims at demonstrating the importance of the source controls in efficient protection of 
health. 
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Figure 2. Flowchart of the health-based ventilation guidelines as defined in the 
HEALTHVENT –project (ECA, 2013) 
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2  Objectives of this report 
Indoor air in Finland and in all studied  European countries is beyond reasonable 
doubt associated with substantial health r isks, estimated to correspond a loss of over 
2 million healthy life years annually. The current w ork aims to sum marize the 
current understanding of the sources of health risks in indoor environments and their 
relationship with ventilation levels (this part of the w ork was conducted in the 
HEALTHVENT project). The results are sp ecifically investigated to understand and 
prioritize alternative strategies to control these health risks (TEKAISU project). To 
accomplish these tasks, w e present a quantitative fram ework for balancing the 
exposures and risks in combination with their sources and ventilation.  
The methods presented here allow for inform ed health-based optim ization of 
efforts aimed at reducing harmful exposures and improving health of the occupants. 
The results are intended for developm ent of national and international guidelines 
and standards, but can be used as bac kground information also in analysing indoor 
air quality related issues in buildings. 
 
Specifically, the current report has the following objectives: 
 
1) To present an overview of the main s ources of health risks present indoors and 
their relative magnitudes. 
 
2) To provide a quantitative fram ework for estim ation of long-term  health effects 
and benefits for EU and Finnish citizen s for protecting them  against health 
risks due to poor indoor air quality in new  and existing non -industrial 
buildings. 
 
3) To quantify the burden of disease by expos ures and by diseases in order to allow 
for implementation of effi cient exposure reduction policies to achieve cost 
effective health benefits. 
 
4) To provide inform ation and m ethods for prioritization of risk m anagement 
policies and resource allocation for be tter health, productivity and welfare, 
ensuring rational use of resources in Europe. 
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3  Indoor exposures and health effects 
The heterogeneity of indoor spaces provides substantial challenges for 
epidemiological studies aim ing at quan tifying the association between indoor 
exposures and health. Am bient epidemiology has been extrem ely successful in 
similar task regarding outdoor air for whic h a small number of monitoring stations 
can be used to estimate exposures of large populations. In the case of indoor studies 
each indoor space has to be m onitored separately, limiting effectively sizes of 
studied populations.  
Moreover, many indoor studies focus m ainly on acute health effects like 
respiratory symptoms and asthm a. Investigating the association of chronic 
conditions, e.g. cardiovascular diseases th at cause a m ajority of the burden of 
disease in the case of ambient pollution, would require long follow-up periods with 
corresponding exposure assessment. 
For these reasons the specific evidence on the association of indoor exposures 
and health is m uch more limited than fo r outdoor air pollution. However, for risk 
assessment purposes there is no need to a ssume that the exposure to an identical 
pollutant indoors would have any different effects than exposure outdoors.  
 
3.1 Scientific evidence on ventilation and health 
 
Direct scientific evidence on the relati onship of ventilation and health is quite 
limited. Recent review of epidem iological studies specifically looking at the 
associations between ventilation levels and health (Carrer et al, 2013) identified only 
few studies that observed a direct link between ventilation levels and health.  
Wargocki et al. (2002) reviewed 105 papers published in peer-reviewed scientific 
journals, out of which 30 papers were j udged to provide sufficient information on 
ventilation, health effects, data pr ocessing, and reporting. V entilation was 
considered strongly associated w ith comfort (perceived air quality) and health 
(including sick building syndrom e (SBS) symptoms, inflammation, infections, 
asthma, allergy, and short-term  sick l eaves), and that an association between 
ventilation and productivity (perform ance of office w ork) was indicated. The group 
also concluded that increasing outdoor  air supply rates in non -industrial 
environments improves perceived air qua lity, but no form al cut-off point or 
recommendation regarding rate for control of  perceived air qual ity was given. In 
some studies outdoor air supply rates below 25 l/s per person increased the risk of 
SBS symptoms, short-term sick leaves , and decreased productivity in office 
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buildings. Ventilation rates above 0.5 air changes per hour (h -1) in hom es reduced 
infestation of house dust m ites in Nordic c ountries. Wargocki et al. noted also that 
improper maintenance, design, and f unctioning of air -conditioning systems 
contributes to increased prevalence of SBS symptoms.  
Similar results were obtained in the re view by Seppänen et al. (2004). They 
concluded that the existing literature i ndicates that ventilation has a significant 
impact on several im portant human outcomes including: (1) com municable 
respiratory illnesses (disease prevalence or sick days); (2) sick building syndrom e 
(SBS) symptoms; (3) task perform ance and productivity, and (4) perceived air 
quality (PAQ) as judged by building occupants or recruited sensory panels of 
assessors; and (5) respiratory allergies and asthma. As regards the quantitative 
requirements the review of Seppanen et al. (2004) showed that ventilation rate up to 
20-25 L/s per person seem  to decrease the prevalence of SBS sym ptoms. Air 
conditioning systems may increase the prevalence of SBS -symptoms relative to 
natural ventilation if not properly m aintained. In residential buildings the authors 
conclude that the air change rate in cold climates should be at least 0.5 h-1.  
Li et al. (2007) perform ed a system atic review of the role of the built 
environment in the transm ission of airbor ne infectious agents. Specifically, they 
examined whether there was sufficiently strong evidence in the current literature to 
substantiate a contributory role of ventilation rates and airflow  patterns in the 
airborne transmission of infectious agents  in d ifferent indoor settings. Li et al. 
concluded that there is strong evidence substantiating the association between 
ventilation, air m ovements in buildings a nd the transm ission/spread of infectious 
diseases such as m easles, tuberculosis, chickenpox, influenza, sm allpox and SARS. 
However there is insufficient data to clear ly define the ventilation rates that can 
reduce the risk of the spread of infecti ous diseases via the airborne route for 
hospitals, schools, offices, homes and isolation rooms. Very often overcrowding was 
identified as a factor that m ay be related to ventilation of buildings. H owever, 
without details of airflow rates, it was di fficult to rigorously demonstrate a direct 
relationship between overcrowding and the airborne transmission of infecti on. 
Moreover, overcrowding may also increase disease transmission via direct contact. 
Sundell et al (2011) identified 27 papers published in peer reviewed journals 
providing sufficient inform ation on both ventilation rates and health effects. 
Multiple health endpoints show ed similar relationships w ith ventilation rate and 
were biologically plausible, although the literature did not provide clear evidence on 
particular agents. Higher ventilation rates in offices, up to about 25 l/s per person, 
were shown in the review ed literature to be associated with reduced prevalence of 
sick building syndrome (SBS) symptoms. Limited data suggested that inflammation, 
respiratory infections, asthm a symptoms and short-term sick leave increase with 
lower ventilation rates. H ome ventilation rates above 0.5 air changes per hour (h -1) 
were shown in the reviewed papers to be associated with reduced risk of allergic 
manifestations among children in a Nordic climate.  
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None of the studies included in the revi ews specifically addresse d the role of 
outdoor air quality on indoor exposures. Neither was the existence of indoor sources 
systematically analysed nor exposure leve ls quantified. Therefore the support from 
these previous studies on determ ining the best combination of source control and 
ventilation levels is limited. 
 
3.2 WHO Air Quality Guidelines  
 
Indoor air quality has been recently lifted to focus by W orld Health Organization, 
which has reviewed the previous expos ure guidelines specifically addressing 
exposure in indoor space (W HO 2009, 2010). Already during the previous two 
decades WHO had coordinated system atic reviews of scientific evidence and set 
Guidelines for Air Quality (WHO 2000b, 1987). These guidelines also w ere defined 
for exposures, even though indoor environments were not in particular focus.  
From the evolution of the W HO Guidelines for Air Quality (Table 2) it can be 
seen that already in the 1980’s most of the pollutants regarded hazardous today were 
included. Only few additions w ere made in the second edition released in 2000 b. 
The Global Update in 2005 focused m ainly in correcting the risk slope approach, 
unfortunately selected in the second edition, and adding fine particles (PM 2.5) to the 
guidelines. The only specific addition in th e work focusing specifically on indoor 
exposures was naphthalene, w hich plays still a significant role especially in 
Mediterranean climate where it is used as an insecticide. 
Notably, the WHO Guidelines for Indoor A ir Quality do not discuss particulate 
matter. The previous Guideline from  the Global Update (WHO, 2005) was left as it 
is and the potential differences in the particulate m atter composition from indoor 
sources were not considered.  
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Table 2. Air pollutants recognized as hazardous to human health in the WHO 
Guidelines for Air Quality and the identified relevant exposure times. 
    Edition of the WHO Guidelines (year of publication) 
      
 Pollutants First Edition Second Edition Global 
Update 
IAQ 
    1987 2000 2006 2010 
      
1 1,2-Dichloroethane 24 h 24 h   
2 Acrylonitrile lifetime lifetime   
3 Arsenic lifetime lifetime   
4 Asbestos lifetime lifetime   
5 Benzene lifetime lifetime  lifetime 
6 Cadmium 1 a 1 a   
7 Carbon disulfide 24 h, 30 min 24 h, 30 min   
8 Carbon monoxide 15 min - 8 h 15 min - 8 h  15 min - 8 h 
9 Chromium lifetime lifetime   
10 Dichloromethane 24 h 1 week, 24 h   
11 Fluoride  1 h   
12 Formaldehyde 30 min 30 min  30 min 
13 Hydrogen sulfide 24 h, 30 min 24 h, 30 min   
14 Lead 1 a 1 a   
15 Manganese 1 a 1 a   
16 Man-made vitreous 
fibres 
 lifetime   
17 Mercury 1 a 1 a   
18 Naphthalene    1 year 
19 Nickel lifetime lifetime   
20 Nitrogen dioxide 1 h 24 h, 1 h 1 year, 1 h 1 year, 1 h 
21 Ozone 1 h, 8 h 8 h 8 h  
22 PM10 24 h days 1 year, 24 h  
23 PM2.5  years 1 year, 24 h  
24 Polycyclic aromatic 
hydrocarbons (PAH) 
lifetime lifetime  lifetime 
25 Radon lifetime lifetime  lifetime 
26 Styrene 24 h, 30 min 1 week, 30 min   
27 Sulphur dioxide 1 hour, 10 min 1 year, 24 h, 10 min 24 h, 10 min  
28 Tetrachloroethylene 24 h, 30 min 1 a, 30 min  1 year 
29 Tobacco smoking (ETS) – lifetime   
30 Toluene 24 h, 30 min 1 week, 30 min   
31 Trichloroethylene 24 h lifetime  lifetime 
32 TSP 24 h    
33 Vanadium 24 h 24 h   
34 Vinyl chloride lifetime, 24 h lifetime   
      
Pollutants with one or more 
guidelines 29 32 4 9 
    
Bold entries highlight the introduction of new/modified averaging times of the WHO guidelines. 
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However, in the parallel process of assessing the carcinogenicity of sm oke from 
solid fuel use and frying, International Ag ency for Cancer Research clearly pointed 
out that the fumes from these activities are human carcinogens (IARC, 2010). 
Substantial fraction of the compounds for which WHO has developed guidelines 
(Table 2; 10 out of 34) are volatile orga nic compounds (VOCs) which in the current 
work are included as a group only. Eight of the pollutant s are metals which are not 
accounted here at all due to the fact that they   mostly play a more significant role in 
the outdoor air than indoors. Asbestos and m an-made vitreous fibres in general are 
significant occupational risks, but play a minor role for the general population. 
The WHO Guidelines for A ir Quality for specific pollutants are quantitative 
exposure levels associated with corresponding averaging times. In the Guidelines for 
Dampness and M ould WHO also recognized a large num ber of qualitative issues 
associated with prevention of dam pness, removal and renovation of all signs of 
moulds, and sufficient m aintenance of the building structures including ventilation 
systems (WHO 2009). While these qualitative guidelines are very significant tools in 
practical risk m anagement, it is challenging to utilize them  as risk factors in risk 
assessment. Therefore the current work is based on the burden of disease approach 
using prevalence of dam pness in residences as the risk indicator  without allocating 
the health risks to specific chemically or biologically defined exposures. 
 
3.3 Exposure analysis 
 
When developing the G uidelines for Air Quality, WHO adopted a quantitative 
approach, linking exposure levels with population health risks and considering 
sufficient safety m argins. This approach is utilized in the current w ork. While the 
actual exposure levels in the existing bu ilding stocks are not always very well 
known, the quantitative relationships of indoor and outdoor sources are, how ever, 
well understood based on mass-balance. 
Ventilation plays a tw o-sided role in form ation of indoor pollutant 
concentrations. The m ain purpose of ventilation is to rem ove indoor generated 
impurities from indoor spaces by ventilating the space w ith fresh outdoor air. A  
constant indoor source leads to an invers e relationship with the ventilation rate; the 
higher the ventilation, the low er the corresponding indoor concentration . As the 
ventilation rate rises, the diluted indoor concentration decreases, but never reaches 
zero (Figure 3). 
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Figure 3. Relative indoor concentration from a constant indoor source as function 
of increasing air exchange rate. 
 
On the other hand, while the ventilation air is taken from outdoors, ventilation 
introduces outdoor air pollutants indoors (Hänninen et al., 2004; Hänninen et al., 
2005). Assuming a constant outdoor pollution level and constant penetration 
efficiency, increasing ventilation directly leads to increased indoor exposures 
(Figure 4). 
Outdoor air has been estimated to be responsible for more than 50% of the 
burden of disease due to indoor exposures in European countries (Oliveira 
Fernandes et al., 2009, Jantunen et al., 2010). European Commission assessment 
based on the extensive air quality monitoring network and complementary statistical 
and physical modelling estimates that only 9% of European Union citizens live in 
areas where the WHO guideline of 10 µg m-3 for annual average PM2.5 concentration 
(WHO, 2006) is achieved (Leeuw & Horalek, 2009). 
Even in the case of efficient filtering of particles in the intake air, detailed studies 
have shown that a substantial fraction of the outdoor air enters indoors via windows, 
doors, ventilation ducts, and cracks and leaks in the building envelope, leading to 
much lower actual filtration efficiency (Fisk et al., 2002).  
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Figure 4. Relative indoor concentration from a constant outdoor level as function 
of increasing air exchange rate. 
 
3.3.1 Quantification of exposures using mass-balance 
 
Due to the counter -acting roles of indoor  and outdoor sources on the exposures as 
function of ventilation rate a m ass-balance model is needed. A  commonly used 
approach was presented as (Dockery & Spengler, 1981): 
 
Eq 1  
where Ci is the total indoor concentration ( µg m-3) of the pollutant in question, Ca is 
the concentration in the air intake, P is the probability of the pollutant rem aining 
suspended after penetrating through the building envelope; a is air exchange rate (h -
1), k is the deposition rate of the pollutant indoors  (h-1), G is the indoor generation 
level (µg h-1), and V is the volum e of the indoor space. The third term  covering the 
transient impacts of changing concentration can be considered zero for the sake of 
long-term average exposures. 
Thus the total indoor concentration of a pollutant is thus effectively split into two 
remaining fractions, one originating from outdoor air (Cai) and the other from indoor 
sources (Cig): 
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Eq 2  
 
Eq 3  
 
As we see from  these equations, the physic o-chemical pollutant properties modify 
the both components. Infiltration is affect ed by both the penetration efficiency ( P) 
and the decay ( k) terms. In practice, the penetr ation efficiency is 1 for any 
component entering the building from  open doors and windows or any cracks and 
openings that are larger than one millimetre.  
The current work accounts for PM 2.5
, pollen and VOC originating from outdoors. 
For particles the decay rate is m ainly driven by therm okinetic and gravim etric 
deposition and thus is strongly dependent on the particle size. For the sim plified 
approach used here the default values shown in Table 3 are used. 
 
Table 3. Mass-balance parameters of the outdoor pollutants considered. 
Pollutant Mass balance parameters 
 Dp(eff) 
µm 
Penetration (P) 
[fraction] 
Density 
g cm-3 
Decay (k) 
h-1 
Finf 
[fraction] 
PM2.5 <2 90 % 1.5 0.14 0.55 
Pollen 10 80 % 1.0 5.41 0.07 
VOC n/a 100 % n/a 0.10 0.69 
Dp(eff) = effective particle diameter; Finf = resulting infiltration factor  at a=0.22 h-1; in the model 
the actual Finf values are calculated according to the used ventilation rates.  
 
Both ultrafine and coarse particles have m uch lower penetration efficiencies and 
higher deposition rates indoors than PM2.5, which is therefore suitable for evaluating 
the health-relevant contribution of outdoor pollution indoors.  
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3.3.2 Determining filtration efficiencies 
 
Long-term WHO guideline for PM2.5 has been set at 10 µg m-3 as an annual average. 
The WHO guideline has been set based on ambient epidemiology conducted using 
urban background monitoring station data on outdoor levels. Depending on the 
building stock in each city of these studies (e.g. 6 in the Harward Six Cities study 
(Dockery et al., 1993); 150 in the American Cancer Society study (Pope et al., 2002), 
the corresponding indoor reference concentration may have varied from 4 to 8 µg m-
3. For the purposes of determining the filtration efficiency in the HEALTHVENT 
ventilation guidelines, a central value of 6 µg m-3 was chosen as the reference 
concentration (Cref). Now the needed effective penetration efficiency for the building 
as whole can be solved from the mass-balance equation as  
 
Eq 4  
 
Even in the case of mechanical ventilation systems using high quality filtering of the 
intake air, the effective penetration efficiency is strongly dependent on the overall 
tightness of the house. Penetration efficiency of particles entering indoors via 
windows, doors and cracks in the building envelope approaches unity, and the 
effective average penetration efficiency is thus determined by the filtration 
efficiency (Pfilter) and fraction of air passing through the filter (f): 
 
Eq 5  
 
Solving for the filter efficiency (Pfilter) yields 
 
Eq 6  
 
Obviously, the filter efficiency has to be balanced against the leakiness of the system 
as in leaky conditions the filter efficiency required may easily exceed 100%. 
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Thus the overall procedure for designing the building in term s of filtering 
outdoor air needs to account for the outdoor pollution level at the building site (C a), 
air exchange rate designed for norm al use ( a), to solve the required effective 
penetration rate (Peff). Additionally, in case of a m echanical ventilation system, the 
leakiness of the building ( f) has to be balanced against the available filter 
efficiencies (Pfilter). Using the PM2.5 decay term (k=0.14 h-1) sufficiently covers also 
pollen and coarse and ultrafine particles having larger deposition velocities and 
typically more efficient filtration properties, too. 
 
3.4 Risk models: Attributable burden of disease 
 
The current enhancement of the health im pact assessment with the above described 
mass-balance approach to account for variable ventilation is built on the previous 
achievements of EnVIE and IAIAQ projec ts (Oliveira Fernandes et al, 2009, 
Jantunen et al., 2010, respectively) and th e corresponding models for environmental 
burden of disease caused by indoor air quality. These m odels were based on 
predefined population attributable burden of disease for each exposure and disease 
and national estimates are then calculate d from national burden of disease data by 
scaling the attributable fraction according to  the ratio of national versus European 
indoor concentration estim ates of each pollutant. In the current work the PM 2.5, 
radon and dampness models were updated to the rel ative risk-based PAF approach 
(Table 4; see Hänninen &  Knol, 2011, fo r methodological details) but keeping the 
IAIAQ disease classification,  which for PM 2.5 slightly differs from  Hänninen &  
Knol (2011). In addition, second hand sm oke exposures were added using exposure 
data from EC, 2009. National exposure level estimates are presented in Appendix A, 
Table A2. 
 
Exposures to environmental pollutants are associated with additional mortality and 
morbidity. Traditional methods estimate these separately as numbers of cases. The 
results from such incidence-based models are not comparable over different types of 
health endpoints and to im prove comparability of im pacts on various types of 
diseases and including m ortality, disability adjusted life years ( DALY) has been 
proposed as a common metric (Murray & Lopez, 1997).  
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The burden of disease methodology is based on making years of life lost (YLL) due 
to premature mortality and years lived with a disability (YLD) comparable and 
summing them up as disability adjusted lifeyears (DALY) (Murray & Lopez, 1997):  
 
Eq 7  
The disabilities caused by various types of diseases are calculated accounting for the 
duration of the disease (L) and scaled using a disease specific disability weight 
(DW): 
 
Eq 8  
 
In the current work the fraction of disease caused by the indoor exposures to various 
pollutants is estimated using national statistics on the overall background burden of 
the target diseases (Table 4) and calculating the population attributable fraction 
(PAF) as (Hänninen & Knol, 2011):  
 
Eq 9  
where f is the fraction of population exposed to a given factor and RR is the relative 
risk of the exposed population. Now if the background burden of disease (BoD) is 
known the environmental burden of disease (EBD) caused by the current exposures 
can be calculated as 
 
Eq 10  
The relative risk at the current exposure level can be estimated from epidemiological 
relative risk (RR°) expressed per a standard exposure increment, e.g. 10 µg m-3:  
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Eq 11  
 
WHO estimates for national burden of disease in 2004 were used for the background 
burden of disease (BoD). 
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4  Exposure control options for indoor air 
Exposures to harmful pollutants indoors are created by the occurrence of pollution 
sources indoors and outdoors. The quantitativ e exposure levels from  these sources 
are balanced w ith ventilation. In som e cases specific ventilation can be used to 
remove the exposures (e.g. target exhaust in kitchen and bathroom ), but general 
ventilation is rather inefficient as an exposure control and cannot be used to 
eliminate exposures. 
This Chapter describes the selected exposure reduction scenarios for which the 
burden of disease benefits is evaluated in  the next Chapter. The exposure reduction 
scenarios are based on the European building stock in 2010 and combine ventilation, 
filtration and source control elements. 
 
4.1 Ventilation in current European building stock 
 
Before it can be estim ated how adjusting ventilation affect s exposures, the 
probability distribution of national baselin e ventilation itself has to be estim ated. 
Surprisingly limited measurement data is  available from  only a subset of the 
included European countries and th e population, house type and seasonal 
representativeness varies quite a lot from study to study. 
The comprehensive review of scientific  publications o n residential ventilation 
rates in European countries by Dim itroulopoulou (2012) was com plemented here 
with two additional approaches to adju st the non-representative datasets w ith 
available other inform ation to obtain best  possible estim ates. First, a regression 
model was used to account for the clim atological and economical differences in the 
building stocks. Further, as part of the HEALTHVENT project, a review of national 
building code requirements for ventilation was conducted (Brelih et al. 2011). These 
three sources of information were combined using a Bayesian subjective probability 
approach for generation of lognormal probability distributions for ventilation rates in 
each EU26 country for the baseline at 2010 (A sikainen et al. 2013). The assumption 
of lognormality of the air exchange rate di stributions was validated against one of 
the most representative international datasets (Figure 5). 
The estimated baseline ventilation rate distributions are listed in Appendix A. 
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Figure 5. Validation of the overall lognormality of ventilation rate variability in four 
European cities (original data from Hänninen et al., 2004). 
 
4.2 Exposure control scenarios 
 
Three alternative exposure control scenarios were eva luated using the mass-balance 
enhanced burden of disease m odel to ev aluate their efficiencies. The exposure 
control scenarios start from  optimizing the ventilation rates only. A s this proves 
inefficient, it is com plemented first w ith control of filtration of outdoor pollutants 
and second with control of indoor sources. 
4.2.1 Dilution by optimal ventilation 
 
Ventilation is needed to rem ove carbon dioxide and hum idity emitted by the 
occupants. Further, for pollutants with higher indoor than outdoor concentrat ions 
ventilation can be used to dilute the indoor levels and thus low er the exposures. 
However, for pollutants with higher outdoor le vels, such as typically e.g. pollen and 
particulate matter, ventilation actually leads to their infiltration. 
The first exposure reduction scenario is defined as finding the health -based 
optimum ventilation rate without any other changes to indoor or outdoor sources. In 
this scenario the pollutant concentrati ons from indoor and outdoor sources com pete 
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so that the pollutants of indoor sources are decreasing and the pollutants from the 
outdoor sources are increasing when the ventilation rate is increased. The health-
based optimum level of ventilation is solved for each country by calculating the 
indoor and outdoor originating components of burden of disease for ventilation rates 
from 0.1 lps pp to 50 lps pp in 0.1 lps steps up to 9.9 lps, in 0.25 lps steps up to 20 
lps pp and in 1 lps pp steps to 50 lps pp (Figure 6). The results are presented in 
Chapter 5.3. 
The calculations assume that all indoor originating exposures follow the mass-
balance dilution. This is not self-evident for several indoor originating pollutants, 
especially radon, dampness and mould and carbon monoxide. Radon infiltrates 
typically from the soil below the buildings, and the infiltration may react to the 
under pressure indoors, which may increase in some ventilation systems at higher 
ventilation rates. Dampness may also be created by condensation and may thus 
increase at higher ventilation rates. Carbon monoxide is lethal at high exposure 
levels and more efficient dilution by higher ventilation may not be sufficient. 
However, for all these pollutants the benefits of higher ventilation rates are 
calculated assuming the mass-balance for a constant source term. 
 
 
 
 
Figure 6. An example of a lognormal probability distribution of ventilation rates in 
Finland (blue line). The grey area represents the probability of prevailing 
ventilation being below a selected target value. 
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4.2.2 Filtration of intake air 
 
Previous analyses of the sources of indoor  exposures have shown that outdoor air is 
a significant source of exposures. Therefore the second scenario was determ ined as 
attempting to control the burden of diseas e by filtrating the exposures orig inating 
from outdoor air. Because both ultrafine and coarse particles and chemically reactive 
pollutants like ozone have low er infiltration factors than PM 2.5, dominated by 
accumulation mode particles, the filtration was specified for PM2.5 particles. 
 Three levels of filtration w ere compared. The baseline estim ates assume that 
90% of the outdoor PM 2.5 mass concentration penetrat es indoors. In addition, 
realistic but increasingly challenging pene tration levels of 70%  and 50%  were 
evaluated. These correspond to effective filtration of PM 2.5 mass concentration by 
27% and 45%, respectively, filtration levels that can be achieved in real buildings at 
least when using m echanical ventilation systems (Fisk et al., 2002). W hen 
discussing the filtration efficiencies of f ilters and the above m entioned penetration 
efficiencies, it has to be noted that the penetration efficiency is defined for the 
building, accounting for leaks and ventilation from windows, doors etc. 
 The health-based optimum ventilation was defined in this scenario also, and used 
when calculating the burden of disease results and the reduction potential com pared 
to the baseline scenario. The results are presented in Chapter 5.3. 
4.2.3 Source control and minimum ventilation (4 lps pp) 
 
The third approach to optim izing ventilation for health focuses first on indoor 
sources of exposures. Now, instead of attemp ting to dilute these sources as they are, 
they are first assum ed to be controlled by other m eans as m uch as technically 
feasible before optimizing the ventilation for health. The assumed control potentials 
for the considered pollutants were 
 
• -90% for radon, carbon monoxide (CO) and second hand smoke (SHS) 
• -50% for volatile organic componds (VOC) and dampness 
• -25% for particulate matter (PM2.5) 
 
These hypothetical source controls were de fined to approach m aximum technically 
feasible reductions. The radon estim ate assumes efficient application and control of 
radon safe construction in radon-prone areas com bined with control of second hand 
smoke exposures known to act synergisti cally with radon . Efficient second hand 
smoke reductions have already been demons trated in Finland and the SH S policies 
are moving forward also on the European level. The carbon monoxide controls were 
aimed to be implemented by compulsory alarms that will allow for identification of 
malfunctioning devices before the risks occur. 
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VOC controls can be reached by com prehensive labelling system s for product 
emissions. Dampness controls need to combine structural im provements with 
active/online and passive warning sensor s. The m ost challenging elem ent was 
considered to be particulate m atter. The proposed 25%  reduction can be achieved 
with target exhausts in kitchens, avoi ding use of candles, and im proved design of 
combustion devices. 
In this scenario the ventilation levels w ere set to be 4 lps pp, w hich has been 
defined as m inimum ventilation in cases where indoor sources are controlled and 
human emissions (i.e. mainly CO2 and moisture) are the only sources (ECA, 2013). 
The results are presented in Chapter 5.3. 
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5  Reduction potential of burden of disease 
The control options of indoor exposures evaluated here are compared with the 
baseline burden of disease in the European building stock in 2010. The health 
impacts are calculated for the implementation of the control options in the whole 
building stock.  
5.1 Attributable burden in 2010 
 
Exposures to indoor and outdoor originating pollutants were associated with a 
burden of disease corresponding to an annual loss of 2.1 million life-years in EU26. 
These estimates are calculated as disability adjusted life-years (DALY) and account 
for loss of life years due to premature mortality and due to years lived with 
disabilities (i.e. morbidity). 
More than half of this burden (1.28 million DALYs) is caused by exposures to 
outdoor air pollution indoors. The remaining 0.74 million DALYs are associated 
with pollutants from various indoor sources Figure 7. 
 
 
 
Figure 7. Attributable burden of diseases due to indoor exposures in 2010 in EU26. 
The lighter shade represents the maximum reducible fraction estimated 
in the following sub chapters. 
The burden of disease caused by indoor exposures is dominated by cardiovascular 
(CV) diseases; 45% of the total burden comes from CV-diseases associated with 
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outdoor particles, with an additional 12 % caused by indoor sources of exposures of 
particles and second hand smoke. Cardiovascular diseases are followed by asthma 
(total of 12%) and lung cancer (23%). The remaining 8% is divided between various 
respiratory symptoms and conditions. 
 The total burden of disease for individual countries varies between 2000 and 
10 000 DALYs per million (Figure 8). The highest burden in Bulgaria is almost five 
times higher than that in Sweden. The higher levels in East-European countries are 
dominated by high contributions from outdoor sources. The contribution of outdoor 
sources varies between 46% (Ireland) to 75% (Bulgaria). The EU26 average burden 
corresponds to slightly over 4000 DALY in a year per one million population. 
 
 
Figure 8. Total burden of disease as DALY/million population from indoor 
exposures in European countries with division to indoor and outdoor 
sources in the 2010 building stock 
5.2 Source contributions 
 
Overall in EU26, over 50% of the total annual burden of disease associated with 
indoor exposures (4000 DALY/million) is estimated to be caused by PM2.5 particles 
originating from outdoor air, followed by particles from indoor sources, and radon 
(Figure 9).  
The contribution of different sources to the total DALY naturally varies between 
countries. This can be seen when comparing the sources of the burden of disease in 
Finland (Figure 9) with the population-weighted mean of EU26 countries. It is 
readily apparent that in Finland the role of ambient particles is lower than in Europe 
in general, but that both bioaerosols (pollen) and radon play much more significant 
roles. Especially the contribution of radon is double to that of the European average, 
highlighting the geology of the Finnish soil. In Finland the burden of disease from 
lung cancer caused by radon exposures is alleviated partly by lower smoking 
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prevalence. In EU27 31% of over 15-year olds smoke daily or occasionally. The 
smoking figures are lower than in Finland (25%) only in Sweden (also 25%) and 
Slovakia (22%) (EC, 2009), indicating the high radon exposures in Finland. 
Dampness and mould problems continuously raise a lot of attention in Finland, 
too. Nevertheless, the burden of disease in Finland is from the lower end on the 
European scale, and only 3% is estimated to be caused by dampness in comparison 
with 5% in EU26. On the other hand, the previous estimate for the symptoms caused 
by dampness and mould in Finland from the national SETURI-study (Pekkanen 
2010, Hänninen et al. 2010) was substantially higher than the current European wide 
HEALTHVENT estimate. 
 The country specific estimates of the burden of disease caused by exposures 
indoors for all EU26 countries are presented in Appendix B. 
Figure 9. Burden of disease attributable to indoor exposures in EU26 (2.1 M DALY/a) 
and in Finland (13 k DALY/a) in 2010 divided into source contributions. 
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5.3 Control scenario benefits including optimal ventilation 
The burden of disease caused by indoor expo sures, estimated above to be over 4000 
DALYs per year per a population of 1 million in EU26, is significant. However, also 
substantial reductions have been proposed in  the earlier work (e.g. Jantunen et al., 
2010). The current w ork made quantitative calculations to confirm  the previous 
expert judgment estimates. 
Three alternative scenarios, described in Chapter 4.2????????????, were developed 
???????????to support policy developm ent for contro lling the risks and reducing the  
???????These evaluated scenarios w ere: (i) D ilution optimum ventilation; (ii)  
???????????optimum; and (iii) Source control w ith 4 lps pp ventilation minimum. The  
??????????are first compared below before presenting the scenario results in more detail 
one???????. 
The first scenario assumes no changes in indoor or outdoor sources and only 
optimizes ventilation to find a m inimum health-weighted exposure level for all 
pollutants. The second option assum es no changes in indoor sources, but applies 
variable levels of filtration to remove a part of the outdoor pollutants from indoor air. 
The third option applies first substantia l controls on the existing m ajor indoor 
sources of exposures before finding the health-based optimum of ventilation.  
The overall com parison of these exposure reduction scenarios i n EU26 is 
presented in Figure 10. 
The achievable health benefits were 20 % for the dilution scenario, 38% for the 
filtration scenario, and 44% for the indoor source control scenario. 
Each control scenario provides noteworthy health benefits. However, in the 
dilution-based scenario 1 the health benefits remain smallest due to the fact that the 
reduction of indoor originating exposures is compensated by infiltration of outdoor 
pollution when increasing ventilation rates. The European health optim um is found 
at ventilation level of 4.4 lps pp, w hich is lower than the baseline m ean ventilation 
in the existing building stock. Approxi mately double benefits are achievable by 
filtration of outdoor air in scenario 2. This scenario w ould in practice im ply 
substantial change towards mechanical ventilation systems in Europe. In the Nordic 
countries this is already the practice due to the energy efficiency norm s, but in the 
majority of the E uropean building stock the filtration scenario w ould require a 
substantial step towards mechanical systems. 
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Figure 10. Burden of disease at the baseline (2010) in comparison with alternative 
potential control strategies in EU26 (in millions of DALYs). 
 
However, largest health benefits can be achieved by the source control approach 
(scenario 3), which significantly reduces the need to control exposures by dilution 
Source control allows also optimizing the ventilation to the level of occupancy. 
Further inspection of the contribution of indoor and outdoor sources on these 
scenarios shows, that with the dilution scenario the health benefit is not due to 
smaller proportion of the indoor contribution (i.e. the dilution of the pollutants from 
the indoor sources) but is based on the lower ventilation rates that actually limits the 
penetration of the outdoor pollutants to indoors. 
In the filtration scenario the health benefits are due to filtration of the outdoor 
pollutants and also effective dilution of the indoor pollutants as the health-based 
optimal ventilation levels are higher.  
Also in the source control scenario 3 the health benefit is a results of both effects; 
the lower indoor sources due to the source control and lower penetration of outdoor 
pollutants due to low level of ventilation. Minimum occupancy based value was set 
at 4 lps pp. The health based optimum was lower than this in some countries, but use 
of such low values rapidly increases the risk of humidity problems. 
The ventilation levels in the dilution and filtration scenarios are country specific 
and based on the maximal achievable health benefits. These health-based optimum 
ventilation levels, burden of diseases as DALY/million and the reduction potentials 
of the dilution and infiltration scenarios are presented in Table 6 and Table 7. In 
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addition the national burden of disease and the reduction potential of the source 
control scenario are presented in Table 8. 
 
Table 5. Comparison of the alternative potential exposure control scenarios. 
	  
Parameters Baseline 
(2010) 
Sce#1 
Dilution 
Sce#2 
Filtration 
Sce#3 
Src Ctrl 
Ventilation     
 Outdoor PM2.5 
penetration 
90 % 90 % 50 % 90 % 
 Ventilation optimuma 
(EU26, lps pp) 
19a 4.4 7.7 <4 
      
Source controls     
 Radon, CO, SHS Baseline None None -90 % 
 VOC Baseline None None -50 % 
 Dampness and moulds Baseline None None -50 % 
 Indoor-generated PM Baseline None None -25 % 
      
Burden of disease  
(million DALY in EU26) 
Baseline 
(2010) 
Sce#1 
Dilution 
Sce#2 
Filtration 
Sce#3 
Src Ctrl 
 Indoor sources 0.74 0.97 0.82 0.38 
 Outdoor sources 1.39 0.74 0.50 0.80 
 Total 2.13 1.71 1.32 1.18 
 % 100.0 % 80.3 % 62.0 % 55.4 % 
     
By Disease group     
 Cardiopulmonaryb 1.27 0.94 0.72 0.78 
 Cancer 0.23 0.26 0.13 0.07 
 Asthma and allergies 0.35 0.24 0.20 0.13 
 Others 0.15 0.14 0.10 0.07 
a	  Population	  weighted	  average	  ventilation	  rate	  in	  EU26	  countries	  at	  baseline	  
b	  Includes	  CV-­‐diseases,	  COPD,	  U&L	  respiratory	  infections/symptoms	  and	  ischaemic	  heart	  disease	  
	  
Efficient reduction   
of indoor ex s r s  
5  Reduction potential of burden of disease 
 
THL — Report 2/2013 43 Burden of Disease from Residential Indoor Air Exposures 
 
 
Scenario 1: Dilution of indoor sources 
The first scenario was defined as finding the health-based optimum ventilation rate 
without any other changes to indoor or outdoor sources (Chapter 4.2.1).  
Modest benefits can be obtained with this approach. At maximum the reduction 
of the burden of disease at a ventilation rate selected commonly for all countries is 
approximately 20%, or 400 000 DALYs in EU26.  
Figure 11 demonstrates how the increasing dilution of exposures from indoor 
sources is counter acted by pollutants from outdoor sources. The minimum of 
burden of disease is found at 4.4 lps pp. When running the health optimization of the 
ventilation rates by countries, the mean value is 7.5 lps pp (Table 6). 
 
 
 
 
Figure 11. Burden of disease as function of residential ventilation rate per person 
in EU26.The national health-based optimum ventilation levels vary 
noticeably between countries the dilution scenario from 1 to 8.8 lps pp 
with EU26 being 4.4 lps pp. The reduction potentials vary between 8% 
and 34% with EU26 being 20%. 
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Table 6. National results for the residual burden of disease from  indoor exposures  in 
the dilution scenario and corresponding relative reduction potential (%). 
Country Optimum 
ventilation 
lps pp 
Indoor 
DALY/million 
Outdoor 
DALY/million 
Total 
DALY/million 
Reduction 
% 
Romania 1.0 3636 2293 5929 27 
Bulgaria 1.7 4080 2519 6598 34 
Poland 2.4 2613 2229 4843 23 
Slovakia 2.5 2397 2277 4674 21 
Latvia 3.1 2209 2144 4353 21 
Lithuania 3.1 2169 1872 4042 18 
UK 3.2 1534 1054 2587 25 
Hungary 3.9 3816 3696 7512 17 
Portugal 4.0 1779 1657 3436 20 
Czech 
Republic 
4.2 3295 2925 6219 16 
Slovenia 4.2 2249 1858 4107 15 
Estonia 4.3 2557 1886 4443 14 
Belgium 4.6 2216 1803 4019 17 
Netherlands 4.6 1866 1356 3222 22 
Germany 4.8 1935 1405 3340 19 
Greece 4.9 2016 2065 4080 16 
Italy 5.1 1749 1457 3206 17 
Finland 5.4 1263 882 2145 15 
Ireland 5.5 1545 840 2386 16 
France 5.6 1521 919 2441 14 
Spain 5.9 1550 1230 2779 13 
Sweden 5.9 1174 838 2012 16 
Cyprus 6.3 1924 1810 3734 11 
Denmark 6.4 1868 1429 3297 16 
Austria 6.9 1881 1419 3301 11 
Luxembourg 8.8 2136 1132 3268 8 
EU-26 4.4 2003 1525 3528 20 
 
Scenario 2: Filtration of outdoor air 
Outdoor air is a significant source of exposures and contributes more than 50% to the 
burden of disease (see e.g . Figure 7 earlier in this Chapter). Therefore the second 
scenario was determined as attempting to control this component by filtrating the 
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exposures originating from outdoor air by comparing three levels of fi ltration 
(Chapter 4.2.2). 
The results for maximum feasible filtration (P=50%) show that reduction in 
burden of disease approach 38 % or 800 000 DALYs in EU26 (Figure 12, Table 7.) 
Average of national health optimums of ve ntilation levels is 5 .7 lps pp an d the 
European optimum is 7.7 lps pp. Health-optimized ventilation level in addition to the 
filtration produces small additional improvements. 
 
 
Figure 12. Burden of disease  for different  levels of ventilation with 50%  filtration of 
ambient particles in 26 EU countries (numerical data in  Table 7). 
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Table 7. National results for the residual burden of disease from  indoor exposures  in 
the filtration scenario and corresponding relative reduction potential (%). 
Country Optimum 
ventilation 
lps pp 
Indoor 
DALY/million 
Outdoor 
DALY/million 
Total 
DALY/million 
Reduction 
% 
Romania 1.7 2844 1853 4697 43 
Bulgaria 2.8 3242 2046 5288 47 
Poland 3.4 2158 1571 3730 41 
Lithuania 4.2 1778 1262 3040 38 
Slovakia 4.2 1741 1747 3488 41 
Latvia 4.4 1847 1488 3335 40 
Portugal 4.7 1614 1033 2647 38 
UK 5.0 1198 813 2011 42 
Slovenia 5.1 1984 1179 3162 35 
Estonia 5.2 2245 1190 3435 34 
Hungary 5.2 3138 2472 5610 38 
Czech 
Republic 
5.5 2719 1947 4666 37 
Netherlands 5.7 1657 885 2542 38 
Belgium 5.9 1896 1188 3084 36 
Germany 6.1 1684 927 2611 37 
Ireland 6.2 1423 531 1954 31 
Finland 6.3 1131 552 1683 33 
France 6.4 1395 570 1965 31 
Italy 6.4 1504 951 2455 36 
Greece 6.6 1656 1372 3027 37 
Sweden 6.8 1063 521 1584 34 
Spain 7.1 1361 776 2137 33 
Cyprus 7.5 1720 1119 2839 32 
Denmark 7.7 1636 911 2547 35 
Austria 8.0 1699 876 2575 31 
Luxembourg 10.0 1990 683 2673 24 
EU26 7.7 1696 1042 2738 38 
 
In the fil tration scenario the national health-based optimum ventilation levels vary 
between countries from 1.7 to 1 0 lps pp with EU26 being 7.7lps pp. The reduction 
potentials vary between 24% and 47% with EU26 being 38%.  
 
Scenario 3: Source control 
 
The third control approach returned the focus to indoor sources of exposures. Now, 
instead of attempting to dilute these sources as they are, they are first assumed to be 
5  Reduction potential of burden of disease 
 
THL — Report 2/2013 47 Burden of Disease from Residential Indoor Air Exposures 
 
controlled by other m eans as m uch as technically feasible before optim izing the 
ventilation for health (see C hapter 4.2.3 for a description on the used em ission 
control estimates). 
The source control ap proach provides slightly larger benefits than the filtration 
approach in the previous scenario; now the benefits are approximately 44% from the 
baseline, or 940 000 DALYs in EU26 Figure 13, Table 8.). 
In this scenario the health optim ums of ventilation rat es are below  4 lps pp, 
where the bioefluent moisture emissions are becoming significant. 
In comparison with the filtration-based s cenario 2 the advantage is that w ith 
source control the low er dilution needs allo w also for low er infiltration of outdoor 
particles and therefore the feasibility of the approach is better in the current building 
stock. Moreover, the source control approa ch is likely to prove also m ore energy 
efficient. 
In the source control scenario ventilati on rate was set to the occupancy based 
minimum of 4 lps pp. The risk reductions ranged from 25%  to 55% with the EU26 
average being 44%. For a majority of the individual countries the largest reduction is 
achieved with source control (Table 8). 
However, e.g. Romania has almost the same reduction potential with the dilution 
and source control scenarios (27 and 25%) and the largest reduction is achieved with 
the filtration scenario (43% ). Also Bulgaria and Slovakia have the largest reduction 
potential with the filtration scenario. T his is clearly due to the larger contribution of 
the outdoor sources than in majority of the European countries. 
 
 
 
Figure 13. Burden of disease for source control and 4 lps pp in EU26. 
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Table 8. National results for the health benefits provided by the source control 
scenario with 4 lps pp.  
Country Indoor 
DALY/million 
Outdoor 
DALY/million 
Total 
DALY/million 
Reduction 
% 
Ireland 593 681 1274 55 
Denmark 732 1033 1765 55 
Sweden 463 643 1106 54 
Finland 486 725 1211 52 
France 662 737 1400 51 
Luxembourg 1096 669 1765 50 
Spain 630 967 1596 50 
Netherlands 832 1231 2063 50 
Italy 693 1245 1937 50 
Austria 885 1004 1889 49 
Germany 894 1242 2136 48 
Estonia 896 1807 2703 48 
UK 574 1230 1805 48 
Czech Republic 1101 2838 3939 47 
Belgium 935 1650 2585 47 
Cyprus 898 1412 2310 45 
Portugal 708 1657 2364 45 
Greece 843 1833 2675 45 
Slovenia 896 1806 2702 44 
Hungary 1358 3753 5110 44 
Lithuania 702 2179 2881 41 
Latvia 868 2500 3368 39 
Bulgaria 1544 4574 6117 39 
Poland 941 3033 3974 37 
Slovakia 823 2999 3821 36 
Romania 1071 5100 6171 25 
EU26 792 1656 2448 44 
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6  Impacts on energy use 
Residential energy use represents roughly a quarter of the total energy consumed in 
Europe (Figure 14). The total energy balance is led by transportation sector (34% of 
energy and 39% of CO2 emissions), followed by the residential sector and industrial 
contributions. 
 
 
Figure 14. Overview of energy use in OECD Europe countries in 2010 (IEA, 2012). 
Transport includes international aviation and navigation. 
The residential energy use includes space heating, lighting and electric appliances, 
cooking and water heating. Air exchange, consisting of intentionally ventilated air as 
well as building leakages, directly affects the heating energy needs during the cold 
season and, optionally, cooling needs in summer. In EU27 approximately 68% of 
energy consumed by the residential sector is used for heating. Additional heat is 
produced by cooking (3.8%) and lighting and other electrical appliances (14%). 
Water heating represents over 13% of the total residential energy use, but this 
energy is mostly lost with waste water and water evaporation (Figure 15a). In 
comparison with the energy used for space heating (nearly 2.5 PWh in EU27), air 
exchange represents almost 40%.  
 
INDUSTRY
24 %
TRANSPORT
34 %
Residential
26 %
Comm. and 
public services
13 %
Agricul ture & 
forestry
2 %
Other
1 %
OECD Europe
Total energy balance
14.5 PWh (1.2 Gtoe)
2010
Efficient reduction   
of indoor exposures  
6  Impacts on energy use 
 
THL — Report 2/2013 50 Burden of Disease from Residential Indoor Air Exposures 
 
 
In the future building stocks, where the insulation of buildings is improved for better 
energy efficiency, the role of air exchange as an energy sink is expected to increase. 
However, if the ventilation is optimized according to the health-based ventilation 
guidelines proposed by the HEALTHVENT project, energy savings are possible 
meanwhile decreasing health risks (Figure 15b). 
 
  
(a) Baseline (b) Src Ctrl scenario in 2010 buildings 
 
Figure 15. Structure of residential energy use (left columns; total in 2010 3.6 PWh/a 
≈ 7,45 TWh/a per million inhabitants) and corresponding energy 
disposal (right columns) in EU27 at the baseline (part a) and assuming 
source controls and the HEALTHVENT ventilation guidelines 
completely implemented (part b) (minimum ventilation of 4 lps pp with 
100% ventilation effectiveness). 
 
6.1 Contribution of air exchange to residential energy use 
 
Using the European ventilation model (Asikainen et al., 2013), we calculated the 
national fractions of residential energy use consumed by ventilation in 2010 (Figure 
16). Higher energy consumptions occur in the Nordic countries and e.g. in 
Luxembourg, where the living space is larger than in many other countries per 
capita. The energy consumption is highest in Finland. 
The potential for energy consumption reduction by ventilation by applying the 
HEALTHVENT ventilation guidelines is shown in Figure 17. Denmark and 
Luxembourg, representing the most spacious living, have the highest baseline 
ventilation energy consumptions followed by Sweden and Finland, with their cold 
climate.  
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Figure 16. Total residential energy use and the fraction consumed by air exchange 
(ventilation and air leakages; in blue) in 2010 (for six countries missing 
2010 data is replaced EEA data for 2009 (EEA, 2012). 
 
 
Figure 17. Residential air exchange energy consumption at the baseline (light blue) 
and the remaining fraction (darker blue) at minimum ventilation 4 lps pp 
and assuming fully effective source controls. 
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6.2 Air exchange energy use 
 
Impact of ventilation on residential energy use was estimated in simulations that 
compared in energy consumptions in three European climates, Helsinki, Paris and 
Lisbon in existing buildings and using modern ventilation technology in future 
buildings (Santos & Leal, 2012). The compared energy use scenarios were: 
 
(i) Baseline: existing building stock and prevailing ventilation in 2010 
(ii)  Guideline: HEALTHVENT minimum ventilation with corresponding indoor 
source control in the existing building stock 
(iii) New building stock built according to current building codes 
(iv)  Potential future building stock with advanced technologies 
 
The results projected substantial energy savings for the current building codes 
and estimated additional energy savings by applying novel energy efficient 
ventilation techniques in the future (Figure 18). The results suggest that the 
implications of ventilation for heating energy needs (shown in Figure 16) can be 
almost removed. The implications of tighter buildings and better insulation on the 
cooling needs were not considered, but are likely to counter-balance some of the 
suggested energy savings. 
 
 
 
 
Figure 18. Comparison of the energy needs of ventilation at the baseline (2010) and 
guideline minimum ventilation (assuming fully implemented source 
controls) in future buildings as simulated by Santos & Leal (2012) in 
three cities. 
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7  Discussion of limitations and uncertainties 
The results from  the studies sum marized in this report suggest that (i) there is a 
substantial burden of disease associated  with inhalation exposures taking place 
indoors and that (ii) these risks have a substantial reduction potential by various 
policies that apply a range of controls affecting indoor sources, infiltration of 
outdoor pollutants, and ventilation levels. The suggested prioritization of the policies 
depends naturally, besides the estim ated health benefits and policy im plementation 
costs, also on the uncertainties in the estimates. The main uncertainties are discussed 
here. 
 
7.1 Attributing health effects 
 
Epidemiological studies on health eff ects caused by indoor exposures typically 
cover acute sym ptoms like wheeze and cough, headache etc. (Carrer et al., 2012).  
Chronic effects are well known for lung cance r and asthm a incidence, but are to 
large extent lacking for cardiovascular and COPD effects. In the current work the 
chronic health endpoints were included using exposure-based risk assessm ent 
models, where the association between individual exposures and health has been 
obtained from more general epidem iological studies, using larger populations and 
specific exposure indicators like residentia l radon concentration (e.g. Darby et al., 
2005, 2006) or ambient PM2.5 concentration (e.g. Pope & Dockery, 2006).  
Variable degree of uncertainty exists in the exposure -response response 
relationships based on epidemiological studies. For some of the included pollutants, 
like PM2.5 originating from  outdoor air, this data is based on a l arge number of 
studies, representing very large populations in different climatological regions. The 
exposure-response relationship of am bient particles has also been used for indoor 
generated particles. The indoor generated particles have partly the sim ilar 
composition, originating from combustion processes or being resuspended particles 
originating from soil, for which it is reasonable to assume similar toxicity as for the 
ambient particles. Some particle fractions, especially the particles from  cooking of 
food, from the occupants, and from  textiles, have a different chem ical composition 
with limited direct evidence on their toxicity. 
Further, in som e cases the population representativeness, number of studies, 
control of confounding and other sources of uncertainties in epidemiological designs 
are much less convincing than in the case of am bient particle, radon, or second hand 
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smoke. Health effects and exposures with weaker evidence have been excluded from 
the models at this point and therefore it is likely that the results are underestim ates. 
However, as those factors that are considered most important are included, the order 
of magnitude of the results should be su fficiently reliable for cost effectiveness 
analyses and policy developm ent. Future refinements will allow for including also 
less dominating effects in the estimates. 
 
7.2 Technical feasibility of lowering the health risks 
 
Three main approaches were investigated  to control the health risks caused by 
indoor exposures in Finland and in other EU26 countries. Each of these approaches 
poses questions affecting both the technical feasibility as well as potential failures in 
implementation of the necessary com ponents for achieving the projected health 
benefits. These are discussed shortly in th is section. Additionally, m aintenance and 
other factors affecting the safety of ventilation systems were also elaborated in detail 
in the HEALTHVENT project (Seppänen et al., 2012). 
7.2.1 Controlling ventilation 
 
A vast m ajority of the E uropean residential buildings were ventilated naturally in 
2010. In natural ventilation system s the m ain factors determ ining the ventilation 
rates are the tem perature differences be tween indoor spaces and outdoor air , wind 
speed, tightness of the building envelope, and availability of openings for ventilation. 
Seasonal and daily variations in tem perature differences and wind speed have to be 
accounted for by adjusting the ventilation openings. Such m anually operated 
adjustment systems require occupant a ttention and activ ity and are not always 
optimal in controlling the exposures. In mechanical ventilation system s electronic 
control units can be program med to adjust ventilation according to the 
environmental changes and the ventilation demand. 
In the future the need to integrate en ergy optimization of ventilation with energy 
efficient tight building envelopes a nd advanced technologies for energy 
conservation like heat pumps and heat recovery units set pressure on equipping more 
buildings with mechanical systems. 
7.2.2 Filtration of ambient particles 
 
More than 90% of Europeans lived in 2005 in areas w here outdoor air quality does 
not meet the W HO Guidelines for PM 2.5 (de Leeuw &  Horalek, 2009). European 
policies for im proving outdoor air quality are constantly developed, but it is 
extremely challenging to low er particle concentrations rapidly. T herefore filtration 
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of the outdoor particles from  the indoor air rem ains a major technology to im prove 
healthiness of indoor spaces. 
Infiltration of ambient particles depends on air exchange rates, s ize distribution 
of the outdoor particles, and filtration of th e intake air. A t lower air exchange rates 
the prolonged residence tim e of air indoors and corresponding deposition of 
particles on indoor surfaces reduces indoor exposures even when the outdoor air is 
not filtrated. U sing window frames and ot her sedimentation chambers allows for 
filtrating particles even in gravim etric ventilation systems. Nevertheless, active 
filtration becomes efficient only in m echanical systems using high quality ( above 
FP7) filters. 
Advanced systems for energy efficiency include heat exchangers and heat pumps, 
which can be integrated w ith balanced mechanical ventilation including filtration of 
intake air. Further reduction of indoor particle levels can be achieved by using filters 
in air recirculation. 
 
7.2.3 Controlling indoor sources 
 
Largest health benefits were projected for the source control policies. It is obvious 
that the benefits are achievable only if th e source controls work as efficiently as 
proposed in Chapter 4.2.3 and that the effi ciency of the source controls m ust be 
confirmed with follow-up of exposure levels after the policy enforcement. 
 
7.2.4 National averages versus individual buildings 
 
The current ventilation rate estim ates per occupant (lps pp) are calc ulated using 
average residence sizes and average num bers of occupants in each country. 
Population weighted average outdoor concen trations have also been used in 
estimating the indoor exposures. It is clear that the air filtration needs for a specific 
building have to be defined using the am bient air quality at the selected building 
location. In all countries included ther e are locations where the outdoor levels 
exceed the W HO guidelines m uch more than the national averages used here 
indicate. When the current methods proposed for determining the potential filtration 
needs, they have to be applied with wors t case estimates for the actual building site, 
accounting for the whole service life. 
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7.3 Risk of insufficient ventilation 
 
Current burden of disease calculations s uggest that low  ventilation levels ranging 
from 4 to 8 lps pp provide benefits in public health. As presented in m ore detail in 
this report, these results are based on various alternative controls affecting indoor 
and outdoor sources of pollution. In the 1970s the tightening of buildings as a 
response to the 1974 energy crisis rapidly led to high exposures from indoor sources 
and massive symptoms of occupants. When applying these ventilation rate estimates, 
strict caution has to be taken to mak e sure that the exposure control assumptions are 
fulfilled to avoid the repetition of such problems. 
 
7.3.1 Controlling dampness in residences 
 
Additional risk assessm ent has to be conducted regarding dam pness. Water is 
intimately integrated w ith our living envi ronments, affected by both weather from  
outdoors as well as living indoors. W ater is emitted by the m etabolism of persons, 
pets and plants, but also by natural hum an activities like dishw ashing, showering, 
laundry and cleaning. Presence of water in t he form of dam pness or hum idity is 
sufficient to lead to rapid proliferation of moulds and other biological organisms 
such as house dust mites.  
World Health Organization (2009) clearly recognizes num erous qualitative 
indicators including any signs of m oisture, dampness or moulds as risk factors and 
recommends to take im mediate action to remediate the conditions. Discussion of 
minimum health-based ventilation rates have to be taken exactly as such: (1) they 
are minimum levels that cannot ever be left unattained; and (2) in the presence of 
additional sources such as humidity, the ventilation has to be adjusted accordingly.  
To highlight this the follow ing simple example is considering very norm al 
household type of activities, including show ering and drying laundry, leading to the 
need of typically 1-5 litres of w ater to be evaporated and transported aw ay from the 
bathroom or drying room. 
The capacity of air to carry water depe nds strongly on the tem perature. As the 
room temperatures are almost always in the order of 20-22 °C, m ostly not differing 
from this value m ore than few  degrees, the m ain variables affecting the drying 
capacity of air are the temperature and humidity of outdoor air.  
Figure 19 presents the am ount of air in cubic m eters needed to transport (dry) 
one litre of evaporated w ater from indoors. In w inter conditions the air entering 
indoors is relatively dry after being heated to the normal room temperature, and thus 
50-100 m3 is sufficient to dry one litre of w ater. However, when the outdoor 
temperature rises – and if the air outdoors remains humid – the amount of drying air 
increases rapidly. 
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Now, the time needed for the ventilation system to provide the requested amount 
of air naturally depends on the ventilation rate. Figure 20 dem onstrates this by 
calculating the drying times, again per one litre of water, at typical ventilation rate at 
the 2010 baseline, 0.5 air changes per hour. In a two-room apartment this correspond 
to roughly 60 m 3 of fresh air in an hour and assuming that one third of this is 
available for the dried space like bathroom, the drying time in winter conditions is in 
the order of 3-5 hours (blue curve). However, if the sam e apartment is designed for 
one occupant with ventilation of 4 lps pp, as show n by the red curve in the figure), 
the drying tim es increase substantially. For a full w ashing machine load (5 kg of 
water) the w inter drying tim e would become already alm ost prohibitively high 60 
hours, but especially in the hum id summer conditions would request more than 240 
hours. Such periods of more than ten days with full humidity indoors would beyond 
any doubt make sure that the space would rapidly become uninhabitable. 
 
 
 
Figure 19. Volume of fresh outdoor air needed to transport one litre of water as 
function of outdoor air temperature and outdoor relative humidity (RH) 
at indoor temperature of +20 °C. 
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Figure 20. Time needed to transport 1 litre of water by ventilation at two discussed 
ventilation levels and assuming 1 third of the air is affecting the space. 
 
Accounting for especially sensitive population groups needs therefore careful 
handling of occupant generated humidity and water from normal household 
activities. New sensor techniques and online systems will allow recognizing 
violations of the good practices in handling humidity. However, common sense 
cannot yet be replaced by intelligent houses. 
In addition to the presence of 'normal' occupant generated humidity there is a 
obviously multitude of other sources for excess moisture indoors, leading to adverse 
health as reviewed by World Health Organisation in 2009. While it is conceivable 
that ventilation may not help to reduce indoor moisture generated by rain- or 
groundwater leakages into the enclosure or plumbing leaks, it is plausible that higher 
ventilation rates support buildings to cope with certain insufficiency in building 
structures etc. that would – at lower ventilation rates - lead to accumulation and 
ultimately excess moisture and subsequent microbial proliferation indoors. It is 
unclear and difficult to predict whether lowering current ventilation guidelines 
would result in an increase of dampness and mould in the building stock. 
 
7.3.2 Microbial exposures 
 
Indoor exposure to microbes and the impact of these exposures on human health is 
highly active field of research, even beyond the discussion of moisture damage, 
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dampness and m ould, in particular refe rring to studies on the role of indoor 
exposures on the developm ent of asthm a and allergy. M icrobes, their structural 
components and secondary m etabolites have been suggested to be involved in both 
protective and adverse m echanisms in particular in respiratory health and allergy 
development.  
Multiple factors, such as timing of exposure, the quantity, quality and potentially 
diversity of m icrobial exposures are rele vant for explaining the observed health 
outcomes. Ventilation and the im pact of ventilation rates on indoor m icrobial 
content and levels have not been studied sy stematically. It is ev ident, however, that 
ventilation rates and types affect indoor microbial exposure. 
The sources for indoor microbes relate to outdoors – e.g. am bient air, outdoor 
particles tracked in on shoes, clothes, etc. – but also have a strong indoor context, as 
in the case of human shedding of microbes, pets, moisture and subsequent microbial 
proliferation. Occupancy is a m ajor determinant of indoor m icrobial levels, both 
through the occupants them selves being an active source of m ainly bacteria, and 
through resuspension of microbes from reservoirs, such as floors and other surfaces. 
Ventilation affects the concentrations of airborne microbial components directly, but 
also to large extent m odifies the i ndoor environmental conditions leading to 
microbial growth. 
 
7.4 Uncertainties of the health risk model 
 
Besides the considerations on the param eter uncertainties affecting the risk 
assessments discussed above, additional sources of uncertainties can be grouped into 
two categories:  
 
(i) Uncertainties in the model 
(ii) Uncertainties in defining the future scenarios.  
 
Model uncertainties are causing the larges t concerns here. They include the 
selection of pollutants and health end-points associated with them and it is clear that 
also in the current context a substantial un certainty raises from here: it is not clear 
how much the burden of disease estim ates are underestim ated due to dozens of 
ignored exposures or m issing health endpoints for the included exposures. At best 
the model uncertainties can be qualitatively judged by experts. A s part of the 
TEKAISU work, THL is evaluating the potential impact of missing pollutants on the 
overall environmental burden of disease. Som e of the pollutants considered m ay 
affect also inhalation exposures indoors. 
In the current work a previously developed burden of disease model from EnVIE 
and IAIAQ studies was used as the platform  for the current work. Several 
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improvements were added for the exposure data for the baseline year 2010, 
including detailed population ba sed outdoor levels of PM 2.5, estimated with 10 km  
spatial resolution for 2005 (de Leeuw & Horalek, 2009). The model was also 
supplemented with second hand smoke exposures from a harmonized recent 
European survey (EC, 2009). To estimate the impacts of ventilation on the burden of 
disease the model was integrated with a single com partment complete mixing mass-
balance model for the estim ation of exposures. The m ass-balance model has been 
validated in experim ental datasets earlie r with good results (e.g. Hänninen et al., 
2004). 
Parameter uncertainties are the easiest to be estimated and evaluated. Standard 
methods applied to the observed data handle sufficiently statistical errors. M ore care 
and expert judgm ent is needed to cover problem s in non-representativeness of 
various population groups. Quantification of  the exposure-response relationships 
and mass-balance model for exposures belong also to the param eter uncertainties. 
Even though the m ass-balance model, assuming e.g. com plete mixing and using a 
single compartment approach does not capture  short-term variations in the actual 
exposure concentrations very well, from the point of view of quantifying the overall 
exposure processes the accuracy is considered good. 
Scenario uncertainties are inherent for any future forecasts; we may not know all 
changes in the system s under scrutiny and therefore m ust rely on assum ptions. 
When selecting policies for im plementation, the im plementation timeframe should 
also be considered. In the case of the nati onal building stocks it is clear that it takes 
years and decades before any new policy may have been fully implemented. 
Most significant elem ent in the scenar io uncertainties is related to the 
development of building stocks in the future. The current ventilation guidelines 
provide some elements that contribute to the need for developm ent in the standard 
building construction technologies. The guide lines are intentionally form ulated so 
that the focus is in the key param eters in terms of health, the exposures, and there is 
as little as possible elements that require specific technical solutions. An example of 
such an issue is the filtration of  outdoor air pollution, especially PM 2.5, but also 
pollen, other biological particles, ozone, ultrafine traffic particles and so on. 
Cleaning of ventilation air seem s to imply using filters and therefore a m echanical 
ventilation system. However, as shown also in the estimates presented in this report, 
low infiltration of ambient particles can be partly obtained by optimizing the balance 
of ventilation rates and indoor sources. It is also possible to develop m ethods to 
reduce infiltration of outdoor pollutants in  traditional ventilation system s. This 
certainly requires m ore applied research and technology developm ent as well as 
careful control of design and implementation. 
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8  Conclusions 
Over 2 m illion disability adjusted life y ears (DALY) are annually lost in the 
European Union due to com promised indoor air quality  including m orbidity and 
mortality due to cardiovascular diseases, lung cancer, asthm a and allergies, acute 
toxication and respiratory diseases cause d by particulate m atter, pollen, radon, 
second hand smoke, dampness and mould, volatile organic com pounds, and carbon 
monoxide exposures that take place in indoor environments. 
Several strategies can be used to reduce this burden . Results from the 
quantitative comparison of thee m ain approaches were presented here: (i) adjusting 
ventilation only; (ii) filtration of air inta ke; and (iii) source control approaches. A ll 
approaches are able to provide substantial reductions in the health risks, but in the 
listed order the reduction potential of the strategies increases from  approximately 20 
% to almost 50%, corresponding to 400 000 and 900  000 saved DALYs in EU26. 
Thus selection of strategies has substantial impact on the expected benefits. 
The projected health benefits can be achieved if the controls on ventilation and 
sources are fully implemented as defined in the scenario descriptions. In the case of 
selecting some of the proposed str ategies for implementation, a careful follow-up 
plan has to be developed for ensuring that the controls are affective and m atch the 
requirements of the benefit calculations. 
THL is currently developing m ethods for quantitative prioritization of 
environmental health protection policie s in the TEKAISU project. The current 
analyses on the health risk reduction pot ential of policies focusing on indoor air 
quality in an im portant input to the w ider analysis of environm ental health risk 
control policies. 
The health-based ventilation guidelines , when combined with the proposed 
efficient control of indoor sources, was estimated to allow reducing the energy 
consumption required by ventilation by 760 TW h/a, or 78 %  in comparison to the 
2010 situation, corresponding 125 M tCO2/a reduction in the carbon dioxide 
emissions in EU27. However, it is essential to consider especially risks in handling 
and removing humidity to avoid sim ilar problems that occurred in the 1970s when 
attempting to reduce energy needs. At that time the haphazardly selected approaches 
resulted in an enorm ous increase in indoor air quality probl ems and associated 
health risks. 
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Appendix A – Baseline ventilation and exposure levels 
Table A.1. Estimated ventilation rate distributions in European countries. 
  
 Air exchange rate Ventilation rate per occupant 
Country Mean Median 
One-GSD  
rangea Mean Median 
One-GSD  
rangea 
 h
-1 h-1 h-1 lps pp lps pp lps pp 
Austria 0.85 0.70 (0.4-1.3) 25 21 (11.1-39.1) 
Belgium 0.71 0.58 (0.3-1.1) 17 14 (7.6-26.7) 
Bulgaria 0.71 0.58 (0.3-1.1) 15 12 (6.4-22.3) 
Cyprus 1.22 1.00 (0.5-1.9) 24 20 (10.6-37.2) 
Czech 
Republic 
0.62 0.51 (0.3-1.0) 14 11 (6.0-21.1) 
Denmark 0.66 0.54 (0.3-1.0) 24 20 (10.4-36.6) 
Estonia 0.66 0.54 (0.3-1.0) 13 10 (5.5-19.4) 
Finland 0.65 0.53 (0.3-1.0) 17 14 (7.5-26.3) 
France 0.64 0.53 (0.3-1.0) 18 14 (7.7-27.1) 
Germany 0.68 0.56 (0.3-1.0) 20 17 (8.8-31.0) 
Greece 0.96 0.79 (0.4-1.5) 20 17 (8.8-30.9) 
Hungary 0.75 0.62 (0.3-1.2) 16 13 (6.8-24.0) 
Ireland 0.57 0.47 (0.3-0.9) 14 12 (6.2-21.9) 
Italy 0.76 0.62 (0.3-1.2) 21 17 (9.2-32.4) 
Latvia 0.65 0.53 (0.3-1.0) 11 9.2 (4.9-17.2) 
Lithuania 0.67 0.55 (0.3-1.0) 11 9.2 (4.9-17.3) 
Luxembourg 0.87 0.71 (0.4-1.3) 32 26 (14.1-49.5) 
Netherlands 0.67 0.55 (0.3-1.0) 21 17 (9.1-32.1) 
Poland 0.69 0.57 (0.3-1.1) 11 8.9 (4.8-16.7) 
Portugal 0.73 0.60 (0.3-1.1) 15 12 (6.6-23.1) 
Romania 0.78 0.64 (0.3-1.2) 7.2 5.9 (3.2-11.1) 
Slovakia 0.78 0.64 (0.3-1.2) 12 10 (5.1-17.9) 
Slovenia 0.72 0.59 (0.3-1.1) 13 11 (5.9-20.7) 
Spain 0.80 0.65 (0.3-1.2) 20 17 (8.9-31.3) 
Sweden 0.64 0.52 (0.3-1.0) 20 17 (9.0-31.5) 
UK 0.61 0.50 (0.3-0.9) 15 13 (6.8-23.8) 
       
EU26 0.70 0.58 (0.3-1.1) 16.6 13.7 (7.3-25.6) 
a (median/GSD, median x GSD) 
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Table A.2. Exposure levels in European countries. 
 PM2.5 PM2.5 VOC VOC Radon Damp SHS 
 Cout Cin Cout Cin Cin homes non-smokers 
 µg m-3 µg m-3 µg m-3 µg m-3 Bq m-3 % % 
Austria 17.2 5.3 103 298 97 8 14 
Belgium 18.7 5.3 103 298 69 14 18 
Bulgaria 22.3 5.0 103 298 30 n/a 23 
Cyprus 22.6 4.0 103 298 7 30 31 
Czech Republic 23.1 5.0 116 334 140 16 16 
Denmark 13.3 2.9 103 298 53 11 17 
Estonia 10.8 2.9 103 298 120 23 16 
Finland 9.1 2.9 64 226 120 5 2 
France 12.3 5.3 77 223 89 14 9 
Germany 16.0 5.3 103 297 50 13 13 
Greece 20.8 4.0 155 345 55 19 28 
Hungary 24.6 5.0 103 298 107 19 12 
Ireland 7.6 2.9 103 298 89 15 14 
Italy 19.6 4.0 181 489 70 21 11 
Latvia 12.4 2.9 103 298 0 26 12 
Lithuania 13.6 2.9 103 298 55 25 28 
Luxembourg 12.1 5.3 52 148 115 15 8 
Netherlands 18.7 5.3 46 134 30 18 15 
Poland 22.2 5.0 103 298 49 37 21 
Portugal 18.3 4.0 38 213 86 20 13 
Romania 22.6 5.0 103 298 45 29 23 
Slovakia 23.1 5.0 103 298 87 6 13 
Slovenia 16.8 5.0 103 298 87 17 14 
Spain 16.4 4.0 103 298 90 18 20 
Sweden 10.4 2.9 77 223 108 6 3 
UK 13.3 2.9 85 245 20 15 7 
        
EU26 17.0 4.5 104 297 64 18 13.9 
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Appendix B – Country results on baseline burden 
 
This section presents the national results  on burden of disease attributable to 
exposures to pollutants present in residen tial indoor air at the baseline in 2010. The 
results are subdivided by diseases and by exposures. 
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Austria 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Austria DALY/million DALY % % %
Cardiovascular (CV) diseases 1 887 15 309 11.6 % 36.5 % 50.9 %
Lung cancer 953 7 728 15.1 % 10.6 % 25.7 %
Asthma (& allergy) 416 3 374 4.7 % 6.5 % 11.2 %
COPD 404 3 280 2.6 % 8.3 % 10.9 %
U&L respiratory infections 28 230 0.8 % 0.0 % 0.8 %
Acute CO toxication 19 156 0.5 % 0.0 % 0.5 %
Total 3 708 30 077 35 % 62 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 2 832 22 969 18.5 % 58.2 % 76.7 %
Radon 426 3 458 11.6 % - 11.6 %
Bioaerosols 129 1 049 - 3.5 % 3.5 %
Second hand smoke (SHS) 187 1 516 5.1 % - 5.1 %
Dampness and mould 50 403 1.3 % - 1.3 %
Volatile organic cmpounds (VOC) 48 389 1.3 % - 1.3 %
Carbon monoxide (CO) 19 156 0.5 % - 0.5 %
Total 3 691 29 941 38.3 % 61.7 % 100.0 %
CV, 51 %
Lung cancer, 26 %
Asthma, 11 %
COPD, 11 %
Respiratory 
infections, 1 %
Toxications, 0 %
Austria
BOD from poor IAQ 
by disease, 2010
PM2.5, 77 %
Radon
, 12 %
Bioaerosols, 3 %
SHS, 5 %
Dampness, 1 %
VOC, 1 %
CO, 1 %
Austria
BOD from poor IAQ
by exposure, 2010
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Belgium 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Belgium DALY/million DALY % % %
Cardiovascular (CV) diseases 2 301 23 689 10.3 % 35.1 % 47.4 %
Lung cancer 1 267 13 045 13.2 % 12.9 % 26.1 %
Asthma (& allergy) 553 5 698 5.4 % 6.0 % 11.4 %
COPD 618 6 359 2.9 % 9.9 % 12.7 %
U&L respiratory infections 96 992 2.0 % 0.0 % 2.0 %
Acute CO toxication 15 159 0.3 % 0.0 % 0.3 %
Total 4 851 49 943 34 % 64 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 3 790 39 016 17.8 % 60.6 % 78.4 %
Radon 447 4 606 9.3 % - 9.3 %
Bioaerosols 150 1 543 - 3.1 % 3.1 %
Second hand smoke (SHS) 203 2 095 4.2 % - 4.2 %
Dampness and mould 170 1 752 3.5 % - 3.5 %
Volatile organic cmpounds (VOC) 56 573 1.2 % - 1.2 %
Carbon monoxide (CO) 15 159 0.3 % - 0.3 %
Total 4 831 49 744 36.3 % 63.7 % 100.0 %
CV, 48 %
Lung cancer, 26 % Asthma, 11 %
COPD, 13 %
Respiratory 
infections, 2 %
Toxications, 0 %
Belgium
BOD from poor IAQ 
by disease, 2010
PM2.5, 79 %
Radon, 9 %
Bioaerosols, 3 %
SHS, 4 %
Dampness, 4 %
VOC, 1 %
CO, 0 %
Belgium
BOD from poor IAQ
by exposure, 2010
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Bulgaria 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Bulgaria DALY/mill ion DALY % % %
Cardiovascular (CV) diseases 8 280 65 953 15.3 % 65.7 % 82.7 %
Lung cancer 904 7 199 3.1 % 6.0 % 9.0 %
Asthma (& allergy) 363 2 890 1.7 % 1.9 % 3.6 %
COPD 212 1 690 0.4 % 1.7 % 2.1 %
U&L respiratory infections 202 1 612 2.0 % 0.0 % 2.0 %
Acute CO toxication 45 362 0.5 % 0.0 % 0.5 %
Total 10 007 79 705 23 % 75 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/mill ion DALY % % %
PM2.5 9 162 72 974 17.4 % 74.3 % 91.7 %
Radon 157 1 251 1.6 % - 1.6 %
Bioaerosols 93 741 - 0.9 % 0.9 %
Second hand smoke (SHS) 243 1 933 2.4 % - 2.4 %
Dampness and mould 260 2 074 2.6 % - 2.6 %
Volatile organic cmpounds (VOC) 35 275 0.3 % - 0.3 %
Carbon monoxide (CO) 45 362 0.5 % - 0.5 %
Total 9 995 79 610 24.8 % 75.2 % 100.0 %
CV, 83 %
Lung cancer, 9 %
Asthma, 4 %
COPD, 2 %
Respiratory 
infections, 2 %
Toxications, 0 %
Bulgaria
BOD from poor IAQ 
by disease, 2010
PM2.5, 92 %
Radon, 2 %
Bioaerosols, 1 %
SHS, 2 %
Dampness, 3 %
VOC, 0 %
CO, 0 %
Bulgaria
BOD from poor IAQ
by exposure, 2010
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Cyprus 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Cyprus DALY/mill ion DALY % % %
Cardiovascular (CV) diseases 2 878 2 290 9.6 % 51.8 % 68.8 %
Lung cancer 334 266 1.8 % 6.2 % 8.0 %
Asthma (& allergy) 612 487 8.6 % 6.1 % 14.6 %
COPD 28 23 0.1 % 0.6 % 0.7 %
U&L respiratory infections 322 256 7.7 % 0.0 % 7.7 %
Acute CO toxication 10 8 0.2 % 0.0 % 0.2 %
Total 4 185 3 331 28 % 65 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/mill ion DALY % % %
PM2.5 3 044 2 423 11.4 % 61.6 % 73.0 %
Radon 16 13 0.4 % - 0.4 %
Bioaerosols 122 97 - 2.9 % 2.9 %
Second hand smoke (SHS) 489 389 11.7 % - 11.7 %
Dampness and mould 443 353 10.6 % - 10.6 %
Volatile organic cmpounds (VOC) 45 36 1.1 % - 1.1 %
Carbon monoxide (CO) 10 8 0.2 % - 0.2 %
Total 4 169 3 318 35.5 % 64.5 % 100.0 %
CV, 69 %
Lung cancer, 8 %
Asthma, 14 %
COPD, 1 %
Respiratory 
infections, 8 %
Toxications, 0 %
Cyprus
BOD from poor IAQ 
by disease, 2010
PM2.5, 73 %
Radon, 0 %
Bioaerosols, 3 %
SHS, 12 %
Dampness, 
11 %
VOC, 1 %
CO, 0 %
Cyprus
BOD from poor IAQ
by exposure, 2010
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Czech Republic 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Czech Republic DALY/million DALY % % %
Cardiovascular (CV) diseases 4 193 42 960 10.0 % 44.3 % 56.4 %
Lung cancer 1 782 18 254 14.1 % 9.9 % 24.0 %
Asthma (& allergy) 613 6 281 3.7 % 4.6 % 8.2 %
COPD 421 4 315 1.0 % 4.6 % 5.7 %
U&L respiratory infections 122 1 252 1.6 % 0.0 % 1.6 %
Acute CO toxication 304 3 112 4.1 % 0.0 % 4.1 %
Total 7 435 76 175 35 % 63 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 5 555 56 911 13.8 % 61.1 % 74.9 %
Radon 873 8 945 11.8 % - 11.8 %
Bioaerosols 160 1 642 - 2.2 % 2.2 %
Second hand smoke (SHS) 242 2 475 3.3 % - 3.3 %
Dampness and mould 212 2 170 2.9 % - 2.9 %
Volatile organic cmpounds (VOC) 67 683 0.9 % - 0.9 %
Carbon monoxide (CO) 304 3 112 4.1 % - 4.1 %
Total 7 412 75 938 36.7 % 63.3 % 100.0 %
CV, 56 %
Lung cancer, 24 %
Asthma, 8 %
COPD, 6 %
Respiratory 
infections, 2 %
Toxications, 4 %
Czech Republic
BOD from poor IAQ 
by disease, 2010
PM2.5, 75 %
Radon
, 12 % Bioaerosols, 2 %
SHS, 3 %
Dampness, 3 %
VOC, 1 %
CO, 4 %
Czech Republic
BOD from poor IAQ
by exposure, 2010
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Denmark 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Denmark DALY/million DALY % % %
Cardiovascular (CV) diseases 1 597 8 547 6.9 % 30.8 % 40.7 %
Lung cancer 887 4 746 11.3 % 11.3 % 22.6 %
Asthma (& allergy) 580 3 104 7.0 % 7.8 % 14.8 %
COPD 690 3 692 3.2 % 14.4 % 17.6 %
U&L respiratory infections 45 240 1.1 % 0.0 % 1.1 %
Acute CO toxication 124 663 3.2 % 0.0 % 3.2 %
Total 3 923 20 992 33 % 64 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 2 837 15 184 13.3 % 59.4 % 72.8 %
Radon 335 1 794 8.6 % - 8.6 %
Bioaerosols 178 955 - 4.6 % 4.6 %
Second hand smoke (SHS) 244 1 305 6.3 % - 6.3 %
Dampness and mould 115 614 2.9 % - 2.9 %
Volatile organic cmpounds (VOC) 66 354 1.7 % - 1.7 %
Carbon monoxide (CO) 124 663 3.2 % - 3.2 %
Total 3 900 20 869 36.0 % 64.0 % 100.0 %
CV, 41 %
Lung cancer, 23 %
Asthma, 15 %
COPD, 17 %
Respiratory 
infections, 1 %
Toxications, 3 %
Denmark
BOD from poor IAQ 
by disease, 2010
PM2.5, 73 %
Radon, 9 %
Bioaerosols, 4 %
SHS, 6 %
Dampness, 3 %
VOC, 2 %
CO, 3 %
Denmark
BOD from poor IAQ
by exposure, 2010
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Estonia 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Estonia DALY/million DALY % % %
Cardiovascular (CV) diseases 2 943 3 937 11.6 % 42.5 % 56.7 %
Lung cancer 1 065 1 425 14.4 % 6.1 % 20.5 %
Asthma (& allergy) 572 765 5.8 % 5.2 % 11.0 %
COPD 98 131 0.4 % 1.5 % 1.9 %
U&L respiratory infections 268 359 5.2 % 0.0 % 5.2 %
Acute CO toxication 246 329 4.7 % 0.0 % 4.7 %
Total 5 192 6 946 42 % 55 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 3 412 4 565 14.2 % 51.8 % 66.0 %
Radon 658 880 12.7 % - 12.7 %
Bioaerosols 168 225 - 3.3 % 3.3 %
Second hand smoke (SHS) 224 299 4.3 % - 4.3 %
Dampness and mould 400 535 7.7 % - 7.7 %
Volatile organic cmpounds (VOC) 62 83 1.2 % - 1.2 %
Carbon monoxide (CO) 246 329 4.8 % - 4.8 %
Total 5 170 6 917 44.9 % 55.1 % 100.0 %
CV, 57 %
Lung cancer, 20 %
Asthma, 11 %
COPD, 2 %
Respiratory 
infections, 5 %
Toxications, 5 %
Estonia
BOD from poor IAQ 
by disease, 2010
PM2.5, 66 %
Radon, 
13 %
Bioaerosols, 3 %
SHS, 4 %
Dampness, 8 %
VOC, 1 %
CO, 5 %
Estonia
BOD from poor IAQ
by exposure, 2010
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Finland 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Finland DALY/million DALY % % %
Cardiovascular (CV) diseases 1 250 6 495 11.8 % 36.6 % 49.7 %
Lung cancer 614 3 192 18.0 % 6.4 % 24.4 %
Asthma (& allergy) 389 2 023 5.0 % 10.5 % 15.5 %
COPD 140 726 1.4 % 4.2 % 5.6 %
U&L respiratory infections 33 172 1.3 % 0.0 % 1.3 %
Acute CO toxication 89 460 3.5 % 0.0 % 3.5 %
Total 2 514 13 067 41 % 58 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 1 665 8 653 16.3 % 50.3 % 66.6 %
Radon 399 2 073 16.0 % - 16.0 %
Bioaerosols 178 927 - 7.1 % 7.1 %
Second hand smoke (SHS) 54 278 2.1 % - 2.1 %
Dampness and mould 65 340 2.6 % - 2.6 %
Volatile organic cmpounds (VOC) 50 261 2.0 % - 2.0 %
Carbon monoxide (CO) 89 460 3.5 % - 3.5 %
Total 2 500 12 994 42.5 % 57.5 % 100.0 %
CV, 50 %
Lung cancer, 24 %
Asthma, 15 %
COPD, 6 %
Respiratory 
infections, 1 %
Toxications, 4 %
Finland
BOD from poor IAQ 
by disease, 2010
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CO, 3 %
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by exposure, 2010
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France 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
France DALY/million DALY % % %
Cardiovascular (CV) diseases 1 102 65 974 11.7 % 26.7 % 38.8 %
Lung cancer 1 031 61 680 23.4 % 12.9 % 36.3 %
Asthma (& allergy) 507 30 353 7.9 % 9.9 % 17.9 %
COPD 137 8 226 1.5 % 3.4 % 4.8 %
U&L respiratory infections 57 3 428 2.0 % 0.0 % 2.0 %
Acute CO toxication 4 246 0.1 % 0.0 % 0.1 %
Total 2 839 169 907 47 % 53 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 1 887 112 931 20.4 % 46.5 % 66.9 %
Radon 500 29 902 17.7 % - 17.7 %
Bioaerosols 173 10 352 - 6.1 % 6.1 %
Second hand smoke (SHS) 68 4 080 2.4 % - 2.4 %
Dampness and mould 142 8 527 5.0 % - 5.0 %
Volatile organic cmpounds (VOC) 48 2 872 1.7 % - 1.7 %
Carbon monoxide (CO) 4 246 0.1 % - 0.1 %
Total 2 822 168 910 47.4 % 52.6 % 100.0 %
CV, 39 %
Lung cancer, 36 %
Asthma, 18 %
COPD, 5 %
Respiratory 
infections, 2 %
Toxications, 0 %
France
BOD from poor IAQ 
by disease, 2010
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Germany 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Germany DALY/million DALY % % %
Cardiovascular (CV) diseases 2 298 189 409 13.6 % 40.2 % 55.8 %
Lung cancer 838 69 099 9.9 % 10.4 % 20.4 %
Asthma (& allergy) 467 38 528 5.3 % 6.0 % 11.4 %
COPD 397 32 678 2.4 % 7.2 % 9.6 %
U&L respiratory infections 66 5 452 1.6 % 0.0 % 1.6 %
Acute CO toxication 51 4 217 1.2 % 0.0 % 1.2 %
Total 4 118 339 382 34 % 64 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 3 315 273 235 20.5 % 60.4 % 80.9 %
Radon 256 21 116 6.2 % - 6.2 %
Bioaerosols 137 11 255 - 3.3 % 3.3 %
Second hand smoke (SHS) 162 13 334 3.9 % - 3.9 %
Dampness and mould 129 10 617 3.1 % - 3.1 %
Volatile organic cmpounds (VOC) 51 4 163 1.2 % - 1.2 %
Carbon monoxide (CO) 51 4 217 1.2 % - 1.2 %
Total 4 100 337 937 36.3 % 63.7 % 100.0 %
CV, 56 %
Lung cancer, 20 %
Asthma, 11 %
COPD, 10 %
Respiratory 
infections, 2 %
Toxications, 1 %
Germany
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Greece 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Greece DALY/million DALY % % %
Cardiovascular (CV) diseases 3 098 33 989 10.1 % 50.9 % 64.1 %
Lung cancer 1 023 11 219 9.0 % 12.2 % 21.2 %
Asthma (& allergy) 356 3 905 3.7 % 3.7 % 7.4 %
COPD 173 1 901 0.6 % 3.0 % 3.6 %
U&L respiratory infections 136 1 493 2.8 % 0.0 % 2.8 %
Acute CO toxication 45 498 0.9 % 0.0 % 0.9 %
Total 4 832 53 005 27 % 70 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 3 925 43 059 13.6 % 67.9 % 81.5 %
Radon 303 3 323 6.3 % - 6.3 %
Bioaerosols 86 946 - 1.8 % 1.8 %
Second hand smoke (SHS) 226 2 475 4.7 % - 4.7 %
Dampness and mould 193 2 114 4.0 % - 4.0 %
Volatile organic cmpounds (VOC) 37 407 0.8 % - 0.8 %
Carbon monoxide (CO) 45 498 0.9 % - 0.9 %
Total 4 815 52 822 30.3 % 69.7 % 100.0 %
CV, 64 %
Lung cancer, 21 %
Asthma, 7 %
COPD, 4 %
Respiratory 
infections, 3 %
Toxications, 1 %
Greece
BOD from poor IAQ 
by disease, 2010
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Hungary 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Hungary DALY/million DALY % % %
Cardiovascular (CV) diseases 5 377 53 352 10.2 % 48.0 % 59.1 %
Lung cancer 2 572 25 518 14.7 % 13.6 % 28.3 %
Asthma (& allergy) 271 2 690 1.3 % 1.7 % 3.0 %
COPD 685 6 796 1.3 % 6.2 % 7.5 %
U&L respiratory infections 83 826 0.9 % 0.0 % 0.9 %
Acute CO toxication 107 1 064 1.2 % 0.0 % 1.2 %
Total 9 095 90 246 30 % 70 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 7 577 75 183 14.7 % 68.7 % 83.4 %
Radon 1 061 10 524 11.7 % - 11.7 %
Bioaerosols 72 710 - 0.8 % 0.8 %
Second hand smoke (SHS) 113 1 118 1.2 % - 1.2 %
Dampness and mould 130 1 292 1.4 % - 1.4 %
Volatile organic cmpounds (VOC) 27 263 0.3 % - 0.3 %
Carbon monoxide (CO) 107 1 064 1.2 % - 1.2 %
Total 9 086 90 154 30.5 % 69.5 % 100.0 %
CV, 59 %
Lung cancer, 28 %
Asthma, 3 %
COPD, 8 %
Respiratory 
infections, 1 %
Toxications, 1 %
Hungary
BOD from poor IAQ 
by disease, 2010
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Ireland 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Ireland DALY/million DALY % % %
Cardiovascular (CV) diseases 950 3 715 7.9 % 20.3 % 33.4 %
Lung cancer 571 2 234 14.5 % 5.6 % 20.1 %
Asthma (& allergy) 956 3 740 17.8 % 15.7 % 33.6 %
COPD 176 690 1.7 % 4.5 % 6.2 %
U&L respiratory infections 147 576 5.2 % 0.0 % 5.2 %
Acute CO toxication 45 178 1.6 % 0.0 % 1.6 %
Total 2 847 11 133 49 % 46 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 1 339 5 239 13.3 % 34.4 % 47.7 %
Radon 347 1 355 12.3 % - 12.3 %
Bioaerosols 307 1 200 - 10.9 % 10.9 %
Second hand smoke (SHS) 346 1 355 12.3 % - 12.3 %
Dampness and mould 309 1 207 11.0 % - 11.0 %
Volatile organic cmpounds (VOC) 114 445 4.1 % - 4.1 %
Carbon monoxide (CO) 45 178 1.6 % - 1.6 %
Total 2 807 10 978 54.7 % 45.3 % 100.0 %
CV, 33 %
Lung cancer, 20 %
Asthma, 34 %
COPD, 6 %
Respiratory 
infections, 5 %
Toxications, 2 %
Ireland
BOD from poor IAQ 
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Italy 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Italy DALY/million DALY % % %
Cardiovascular (CV) diseases 2 041 117 297 8.9 % 42.3 % 53.0 %
Lung cancer 991 56 952 12.3 % 13.4 % 25.7 %
Asthma (& allergy) 438 25 199 5.6 % 5.8 % 11.4 %
COPD 261 14 978 1.2 % 5.6 % 6.8 %
U&L respiratory infections 72 4 149 1.9 % 0.0 % 1.9 %
Acute CO toxication 45 2 610 1.2 % 0.0 % 1.2 %
Total 3 848 221 185 31 % 67 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 2 972 170 810 13.6 % 64.1 % 77.7 %
Radon 358 20 586 9.4 % - 9.4 %
Bioaerosols 108 6 197 - 2.8 % 2.8 %
Second hand smoke (SHS) 125 7 192 3.3 % - 3.3 %
Dampness and mould 150 8 617 3.9 % - 3.9 %
Volatile organic cmpounds (VOC) 66 3 776 1.7 % - 1.7 %
Carbon monoxide (CO) 45 2 610 1.2 % - 1.2 %
Total 3 824 219 789 33.1 % 66.9 % 100.0 %
CV, 53 %
Lung cancer, 26 %
Asthma, 11 %
COPD, 7 %
Respiratory 
infections, 2 %
Toxications, 1 %
Italy
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Latvia 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Latvia DALY/million DALY % % %
Cardiovascular (CV) diseases 3 926 9 145 13.3 % 55.6 % 71.1 %
Lung cancer 731 1 703 7.3 % 5.9 % 13.2 %
Asthma (& allergy) 395 919 3.7 % 3.5 % 7.1 %
COPD 87 203 0.3 % 1.3 % 1.6 %
U&L respiratory infections 283 658 5.1 % 0.0 % 5.1 %
Acute CO toxication 101 234 1.8 % 0.0 % 1.8 %
Total 5 523 12 863 32 % 66 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 4 376 10 192 15.4 % 64.1 % 79.5 %
Radon 320 746 5.8 % - 5.8 %
Bioaerosols 115 268 - 2.1 % 2.1 %
Second hand smoke (SHS) 170 395 3.1 % - 3.1 %
Dampness and mould 383 893 7.0 % - 7.0 %
Volatile organic cmpounds (VOC) 43 99 0.8 % - 0.8 %
Carbon monoxide (CO) 101 234 1.8 % - 1.8 %
Total 5 508 12 828 33.8 % 66.2 % 100.0 %
CV, 71 %
Lung cancer, 13 %
Asthma, 7 %
COPD, 2 %
Respiratory 
infections, 5 %
Toxications, 2 %
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Lithuania 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Lithuania DALY/million DALY % % %
Cardiovascular (CV) diseases 3 531 12 236 11.3 % 51.8 % 71.9 %
Lung cancer 648 2 247 6.6 % 6.6 % 13.2 %
Asthma (& allergy) 256 889 2.9 % 2.3 % 5.2 %
COPD 223 772 0.8 % 3.7 % 4.5 %
U&L respiratory infections 240 831 4.9 % 0.0 % 4.9 %
Acute CO toxication 15 51 0.3 % 0.0 % 0.3 %
Total 4 914 17 026 27 % 64 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 3 768 13 056 13.8 % 63.0 % 76.8 %
Radon 247 857 5.0 % - 5.0 %
Bioaerosols 66 229 - 1.3 % 1.3 %
Second hand smoke (SHS) 489 1 694 10.0 % - 10.0 %
Dampness and mould 296 1 025 6.0 % - 6.0 %
Volatile organic cmpounds (VOC) 25 85 0.5 % - 0.5 %
Carbon monoxide (CO) 15 51 0.3 % - 0.3 %
Total 4 905 16 996 35.6 % 64.4 % 100.0 %
CV, 72 %
Lung cancer, 13 %
Asthma, 5 %
COPD, 5 %
Respiratory 
infections, 5 %
Toxications, 0 %
Lithuania
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Luxembourg 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Luxembourg DALY/million DALY % % %
Cardiovascular (CV) diseases 1 567 701 13.3 % 29.9 % 44.3 %
Lung cancer 992 444 19.4 % 8.6 % 28.1 %
Asthma (& allergy) 506 226 6.4 % 7.9 % 14.3 %
COPD 317 142 2.8 % 6.2 % 9.0 %
U&L respiratory infections 113 51 3.2 % 0.0 % 3.2 %
Acute CO toxication 40 18 1.1 % 0.0 % 1.1 %
Total 3 535 1 581 46 % 53 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 2 418 1 082 21.1 % 47.5 % 68.6 %
Radon 547 245 15.5 % - 15.5 %
Bioaerosols 175 78 - 5.0 % 5.0 %
Second hand smoke (SHS) 106 48 3.0 % - 3.0 %
Dampness and mould 205 92 5.8 % - 5.8 %
Volatile organic cmpounds (VOC) 32 14 0.9 % - 0.9 %
Carbon monoxide (CO) 40 18 1.1 % - 1.1 %
Total 3 524 1 576 47.5 % 52.5 % 100.0 %
CV, 45 %
Lung cancer, 28 % Asthma, 14 %
COPD, 9 %
Respiratory 
infections, 3 %
Toxications, 1 %
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Netherlands 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Netherlands DALY/million DALY % % %
Cardiovascular (CV) diseases 1 830 29 409 9.7 % 33.3 % 44.5 %
Lung cancer 959 15 403 8.9 % 14.4 % 23.3 %
Asthma (& allergy) 684 10 995 7.8 % 8.8 % 16.6 %
COPD 477 7 670 2.6 % 9.0 % 11.6 %
U&L respiratory infections 118 1 894 2.9 % 0.0 % 2.9 %
Acute CO toxication 45 730 1.1 % 0.0 % 1.1 %
Total 4 114 66 100 33 % 66 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 3 219 51 719 17.8 % 60.7 % 78.5 %
Radon 184 2 954 4.5 % - 4.5 %
Bioaerosols 196 3 143 - 4.8 % 4.8 %
Second hand smoke (SHS) 186 2 994 4.5 % - 4.5 %
Dampness and mould 240 3 856 5.8 % - 5.8 %
Volatile organic cmpounds (VOC) 33 523 0.8 % - 0.8 %
Carbon monoxide (CO) 45 730 1.1 % - 1.1 %
Total 4 103 65 919 34.6 % 65.4 % 100.0 %
CV, 44 %
Lung cancer, 23 %
Asthma, 17 %
COPD, 12 %
Respiratory 
infections, 3 %
Toxications, 1 %
Netherlands
BOD from poor IAQ 
by disease, 2010
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Poland 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Poland DALY/million DALY % % %
Cardiovascular (CV) diseases 3 901 150 658 11.4 % 48.9 % 62.1 %
Lung cancer 1 301 50 252 8.4 % 12.4 % 20.7 %
Asthma (& allergy) 612 23 642 5.2 % 4.5 % 9.7 %
COPD 192 7 402 0.6 % 2.5 % 3.1 %
U&L respiratory infections 231 8 921 3.7 % 0.0 % 3.7 %
Acute CO toxication 45 1 754 0.7 % 0.0 % 0.7 %
Total 6 282 242 629 30 % 68 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 5 104 197 116 15.5 % 66.0 % 81.5 %
Radon 334 12 903 5.3 % - 5.3 %
Bioaerosols 136 5 268 - 2.2 % 2.2 %
Second hand smoke (SHS) 199 7 689 3.2 % - 3.2 %
Dampness and mould 395 15 264 6.3 % - 6.3 %
Volatile organic cmpounds (VOC) 51 1 955 0.8 % - 0.8 %
Carbon monoxide (CO) 45 1 754 0.7 % - 0.7 %
Total 6 265 241 950 31.8 % 68.2 % 100.0 %
CV, 62 %
Lung cancer, 21 %
Asthma, 10 %
COPD, 3 %
Respiratory 
infections, 3 %
Toxications, 1 %
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Portugal 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Portugal DALY/million DALY % % %
Cardiovascular (CV) diseases 2 390 24 021 10.0 % 44.5 % 55.8 %
Lung cancer 733 7 362 9.2 % 8.0 % 17.1 %
Asthma (& allergy) 596 5 991 6.7 % 7.2 % 13.9 %
COPD 345 3 463 1.5 % 6.6 % 8.0 %
U&L respiratory infections 172 1 727 4.0 % 0.0 % 4.0 %
Acute CO toxication 45 456 1.1 % 0.0 % 1.1 %
Total 4 281 43 021 32 % 66 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 3 260 32 758 14.0 % 62.2 % 76.3 %
Radon 308 3 096 7.2 % - 7.2 %
Bioaerosols 169 1 700 - 4.0 % 4.0 %
Second hand smoke (SHS) 157 1 582 3.7 % - 3.7 %
Dampness and mould 288 2 898 6.7 % - 6.7 %
Volatile organic cmpounds (VOC) 45 450 1.0 % - 1.0 %
Carbon monoxide (CO) 45 456 1.1 % - 1.1 %
Total 4 273 42 941 33.8 % 66.2 % 100.0 %
CV, 56 %
Lung cancer, 17 %
Asthma, 14 %
COPD, 8 %
Respiratory 
infections, 4 %
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Romania 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Romania DALY/million DALY % % %
Cardiovascular (CV) diseases 6 061 135 700 13.6 % 58.9 % 74.1 %
Lung cancer 960 21 484 4.6 % 7.2 % 11.7 %
Asthma (& allergy) 259 5 800 1.6 % 1.6 % 3.2 %
COPD 318 7 120 0.7 % 3.2 % 3.9 %
U&L respiratory infections 532 11 902 6.5 % 0.0 % 6.5 %
Acute CO toxication 45 1 017 0.6 % 0.0 % 0.6 %
Total 8 175 183 023 28 % 71 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 7 038 157 566 16.1 % 70.0 % 86.2 %
Radon 229 5 117 2.8 % - 2.8 %
Bioaerosols 61 1 365 - 0.7 % 0.7 %
Second hand smoke (SHS) 181 4 051 2.2 % - 2.2 %
Dampness and mould 591 13 225 7.2 % - 7.2 %
Volatile organic cmpounds (VOC) 23 507 0.3 % - 0.3 %
Carbon monoxide (CO) 45 1 017 0.6 % - 0.6 %
Total 8 167 182 847 29.2 % 70.8 % 100.0 %
CV, 74 %
Lung cancer, 12 %
Asthma, 3 %
COPD, 4 %
Respiratory 
infections, 6 %
Toxications, 1 %
Romania
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Slovakia 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Slovakia DALY/million DALY % % %
Cardiovascular (CV) diseases 4 236 22 865 12.7 % 56.6 % 71.3 %
Lung cancer 1 051 5 673 8.7 % 9.0 % 17.7 %
Asthma (& allergy) 353 1 904 2.2 % 3.7 % 5.9 %
COPD 195 1 051 0.6 % 2.7 % 3.3 %
U&L respiratory infections 75 403 1.3 % 0.0 % 1.3 %
Acute CO toxication 31 170 0.5 % 0.0 % 0.5 %
Total 5 940 32 066 26 % 72 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 5 096 27 507 15.8 % 70.1 % 86.0 %
Radon 393 2 119 6.6 % - 6.6 %
Bioaerosols 104 563 - 1.8 % 1.8 %
Second hand smoke (SHS) 167 901 2.8 % - 2.8 %
Dampness and mould 97 525 1.6 % - 1.6 %
Volatile organic cmpounds (VOC) 39 209 0.7 % - 0.7 %
Carbon monoxide (CO) 31 170 0.5 % - 0.5 %
Total 5 927 31 993 28.1 % 71.9 % 100.0 %
CV, 71 %
Lung cancer, 18 %
Asthma, 6 %
COPD, 3 %
Respiratory 
infections, 1 %
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Slovenia 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Slovenia DALY/million DALY % % %
Cardiovascular (CV) diseases 2 391 4 749 11.2 % 36.9 % 49.3 %
Lung cancer 1 270 2 522 14.9 % 11.3 % 26.2 %
Asthma (& allergy) 588 1 168 5.8 % 6.3 % 12.1 %
COPD 334 664 1.6 % 5.3 % 6.9 %
U&L respiratory infections 163 323 3.4 % 0.0 % 3.4 %
Acute CO toxication 106 211 2.2 % 0.0 % 2.2 %
Total 4 852 9 636 39 % 60 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 3 542 7 034 17.2 % 56.1 % 73.3 %
Radon 544 1 081 11.3 % - 11.3 %
Bioaerosols 164 326 - 3.4 % 3.4 %
Second hand smoke (SHS) 154 306 3.2 % - 3.2 %
Dampness and mould 260 516 5.4 % - 5.4 %
Volatile organic cmpounds (VOC) 61 121 1.3 % - 1.3 %
Carbon monoxide (CO) 106 211 2.2 % - 2.2 %
Total 4 831 9 595 40.5 % 59.5 % 100.0 %
CV, 49 %
Lung cancer, 26 %
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COPD, 7 %
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Spain 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Spain DALY/million DALY % % %
Cardiovascular (CV) diseases 1 428 58 517 8.6 % 34.5 % 44.8 %
Lung cancer 961 39 378 17.2 % 12.9 % 30.1 %
Asthma (& allergy) 447 18 298 7.0 % 7.0 % 14.0 %
COPD 275 11 257 1.7 % 6.9 % 8.6 %
U&L respiratory infections 70 2 881 2.2 % 0.0 % 2.2 %
Acute CO toxication 11 431 0.3 % 0.0 % 0.3 %
Total 3 191 130 762 37 % 61 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 2 276 93 252 14.4 % 57.2 % 71.7 %
Radon 435 17 823 13.7 % - 13.7 %
Bioaerosols 121 4 966 - 3.8 % 3.8 %
Second hand smoke (SHS) 142 5 824 4.5 % - 4.5 %
Dampness and mould 146 5 982 4.6 % - 4.6 %
Volatile organic cmpounds (VOC) 45 1 843 1.4 % - 1.4 %
Carbon monoxide (CO) 11 431 0.3 % - 0.3 %
Total 3 175 130 122 38.9 % 61.1 % 100.0 %
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Sweden 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
Sweden DALY/million DALY % % %
Cardiovascular (CV) diseases 1 213 10 753 10.8 % 38.0 % 50.8 %
Lung cancer 578 5 123 16.8 % 7.4 % 24.2 %
Asthma (& allergy) 334 2 962 4.8 % 9.2 % 14.0 %
COPD 191 1 694 1.8 % 6.2 % 8.0 %
U&L respiratory infections 34 302 1.4 % 0.0 % 1.4 %
Acute CO toxication 37 326 1.5 % 0.0 % 1.5 %
Total 2 386 21 160 37 % 61 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 1 667 14 781 15.6 % 54.7 % 70.3 %
Radon 347 3 080 14.6 % - 14.6 %
Bioaerosols 141 1 252 - 6.0 % 6.0 %
Second hand smoke (SHS) 76 678 3.2 % - 3.2 %
Dampness and mould 65 574 2.7 % - 2.7 %
Volatile organic cmpounds (VOC) 39 347 1.7 % - 1.7 %
Carbon monoxide (CO) 37 326 1.5 % - 1.5 %
Total 2 373 21 039 39.4 % 60.6 % 100.0 %
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United Kingdom 
 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
United Kingdom DALY/million DALY % % %
Cardiovascular (CV) diseases 1 563 92 335 7.8 % 34.9 % 45.2 %
Lung cancer 531 31 338 5.2 % 10.1 % 15.4 %
Asthma (& allergy) 780 46 072 9.8 % 12.8 % 22.6 %
COPD 386 22 793 2.0 % 9.1 % 11.2 %
U&L respiratory infections 151 8 908 4.4 % 0.0 % 4.4 %
Acute CO toxication 45 2 682 1.3 % 0.0 % 1.3 %
Total 3 456 204 129 30 % 67 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 2 476 146 273 13.2 % 59.1 % 72.2 %
Radon 99 5 868 2.9 % - 2.9 %
Bioaerosols 263 15 522 - 7.7 % 7.7 %
Second hand smoke (SHS) 175 10 331 5.1 % - 5.1 %
Dampness and mould 289 17 070 8.4 % - 8.4 %
Volatile organic cmpounds (VOC) 80 4 737 2.3 % - 2.3 %
Carbon monoxide (CO) 45 2 682 1.3 % - 1.3 %
Total 3 428 202 485 33.3 % 66.7 % 100.0 %
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EU26 
 
 
 
Disease Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
EU26 DALY/million DALY % % %
Cardiovascular (CV) diseases 2 449 1 184 005 11.1 % 42.7 % 55.6 %
Lung cancer 963 465 487 10.9 % 11.0 % 21.9 %
Asthma (& allergy) 513 247 903 5.5 % 6.2 % 11.6 %
COPD 310 149 715 1.5 % 5.5 % 7.0 %
U&L respiratory infections 124 59 839 2.8 % 0.0 % 2.8 %
Acute CO toxication 46 22 141 1.0 % 0.0 % 1.0 %
Total 4 403 2 129 090 33 % 65 % 100.0 %
Exposure Burden of disease in 2010 Source contributions Percentage of
Indoor Outdoor National BoD
DALY/million DALY % % %
PM2.5 3 424 1 655 488 16.3 % 61.8 % 78.1 %
Radon 343 165 717 7.8 % - 7.8 %
Bioaerosols 150 72 519 - 3.4 % 3.4 %
Second hand smoke (SHS) 158 76 336 3.6 % - 3.6 %
Dampness and mould 212 102 537 4.8 % - 4.8 %
Volatile organic cmpounds (VOC) 53 25 474 1.2 % - 1.2 %
Carbon monoxide (CO) 46 22 141 1.0 % - 1.0 %
Total 4 385 2 120 212 34.8 % 65.2 % 100.0 %
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Lung cancer, 22 %
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Respiratory 
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